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Abstract
The integration of multiple sources of Sonic Hedgehog in the spinal cord contribute to the
production of first-born oligodendrocyte precursor cells which become critical for synapse
remodeling in response to adult motor neuron injury
by
Lev Starikov

Oligodendrocyte precursor cells (OPCs) arise sequentially first from a ventral and then from a
dorsal precursor domain during spinal cord development. Whether the sequential production of
OPCs is of physiological significance has not been examined. Here I show that interrupting
Sonic hedgehog (Shh) signaling originating from nascent ventricular zone derivatives (VZD),
motor neurons and the lateral floor plate, almost completely blocks ventral but not dorsal
oligodendrogenesis without noticeably affecting early tissue patterning and embryonic
development. In the absence of ventral OPCs, dorsal OPCs increase proliferation and populate
the entire spinal cord with increased density. In these mutant mice, dOPCs take on a unique
“bushy” morphology and in contrast to their ventral counterparts, do not participate in pruning of
excitatory synapses from injured motor neurons. My results reveal a unique ability of ventrally
produced OPCs to communicate with post-natal motor neurons and suggests a mechanism by
which progressively greater amounts of Shh emanating from nascent motor neurons allows
greater numbers of oligodendrocytes to be produced at brachial limb levels compared to thoracic
segments.

iv

Acknowledgements
This PhD has been the most challenging thing I have ever attempted in my life. I know that there
was no way I could have kept going through all the struggles without a lot of support from my
mentor, family, and my friends.

PhD Supervisor and mentor, Dr. Andreas H. Kottmann, developed the scientist I have become.

Lab members:
Lauren Malave, Dustin Zuelke, Andres Stucky, were around for the day to day struggle.
Undergraduate Students:
Abin Sajan, Jessalyn Shen, Mahmud Ashik, Kashaf Khatri, Gary Ye, helped with my work.

Dr. Alicia Meléndez, who was the first one to give me a chance.

Thesis Committee members:
Dr. John Martin, Dr. Mark Emerson, Dr. Serge Przedborski, Dr. Neil Shneider

Family
My parents, Mark and Tanya Starikov, were the most understanding of anyone.
My brother Andrey Lazarev and sister in law Tsyrema Lazarev

v

Friends
Who struggled alongside me:
Diego Buenaventura, Monika Buczek, and Zayd Daruwala

Who were there since the beginning:
Tony Sofio, Arkadiy Kusayev, Simon Li, Christopher Rovira, Dani Bencia, Linda Du,
William Xie, Yin Deng, Jennifer Peng

Who kept me on the right path:
Katherine Colon, Syed Hasan, Gregory Lallos, James Clark, Marko Baloh, John Dennehy

Who helped me keep going:
Kevin Cheng, Francesca Grinblat, Jagraj Singh, John Kalambogias, Amy Ziegner, all my
Science Alliance and Hunter College friends.

Who convinced me I could get a PhD:
Sara Wong, Kristina Ames, Melissa Silvestrini, Nick Palmisano

Thomas Jessell and Susan Morton for sharing beautiful antibodies.
William Richardson and Richa Tripathi for sharing tissue that was key for finishing my thesis.
Harry Acosta, Alfredo Diaz, Anthony Pacheco, and Iris Falquez for taking care of my mice.
Jorge Morales for managing the confocal microscope I lived on.

vi

Dedication

This work is dedicated to my grandfather, Yakov Starikov (1928-2000)
Who was there for me above everything else.

It is extremely dangerous to assign value to negative results
– Santiago Ramón y Cajal

Did they get you to trade
Your heroes for ghosts?
Hot ashes for trees?
Hot air for a cool breeze?
Cold comfort for change?
Did you exchange
A walk on part in the war
For a lead role in a cage?
Wish You Were Here, Pink Floyd

vii

Preface
How does a single cell develop into a multicellular organism with incredibly complex tissues
such as the brain or spinal cord? This question has been asked and continuously worked on for
hundreds of years. The central nervous system (CNS) is highly complex compared to many other
tissues as it is composed of hundreds of different cell types. To solve the problem of specifying
hundreds of unique cell types in the CNS, nature operates in 4 dimensions of spacetime and often
recycles the same signaling molecules.
The most efficient form of encoding information in a 3-dimensional space using a single
molecule is with a gradient. A gradient can be established with several mechanisms that create
areas of high to low concentration. Concentration encodes information that is translated into gene
expression regulatory networks. The temporal control of the duration of the gradient creates a
precise window of activity that adds a fourth dimension of specificity. Morphogen gradients are
used throughout the development of the CNS where numerous molecules are acting in concert to
create a cellular 4D cartesian coordinate space that allows for unique combinatorial gene
expression profiles specifying cell fate. For decades of developmental neurobiology
morphogenic gradients were the backbone mechanism explaining cell fate specification in the
neural tube.
Gradients, however, are limited due to the properties of diffusion as a function of tissue size.
What happens when tissue growth renders a gradient insufficient to determine cell fate during
development? I propose here a mechanism of the same signaling molecule that was secreted by
an organizing center being endowed to the first-born neurons that then feedback to the neural
stem cell niche from which they came to specify the next round of cellular specification.
viii

With the understanding of temporal and spatial organizing centers in the developing CNS, I
developed a viable hypomorphic morphogen mouse model which allowed for the investigation of
ventricular zone derived sources of Shh influencing oligodendrogenesis in the first part of my
thesis. Analysis of postnatal mutant transgenic animals revealed morphological and functional
differences in response to injury between cells of different oligodendrocyte lineage in the second
part of my thesis. My thesis work underscores the value of understanding developmental biology
and the incredibly precise engineering of the vertebrate central nervous system to uncover
intrinsic heterogeneity among oligodendrocytes and oligodendrocyte precursors.
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CHAPTER 1:
Introduction to CNS development

1.1 Development of the neural tube
1.1.1 Specification of neural progenitors in the developing CNS
A fertilized cell will complete 4-5 rounds of division to form a solid ball of cells called a morula.
The morula will then transform into a blastula when a cavity is formed and filled with fluid by
the external trophoblast cells. Gastrulation prompts the specification to form the three germ
layers (endoderm, mesoderm, and ectoderm) that give rise to all the tissues of the body. The
ectoderm gives rise to the epidermis and CNS, but what are the signaling factors controlling this
initial fate decision? Dissociated ectodermal cells acquire neural fate when cultured separately,
while intact cultured ectodermal tissue acquires epidermal characteristics, pointing to intrinsic
ectoderm cell-cell signaling regulating epidermis-neuronal fate decisions. Additionally, classical
transplantation experiments in amphibian embryos done by Hans Spemann and Hilde Mangold
demonstrated that the ectoderm is induced to form the CNS by secreted signals from a
mesodermally derived rod-like tissue called the notochord that they termed the organizer region.
Taken together, these results suggested that the notochord secretes signals that inhibit the default
epidermal fate and promote the alternative neural fate in presumptive CNS ectoderm.
With the advent of more sophisticated molecular biology techniques, bone morphogenetic
proteins (BMPs) were found to be expressed by ectoderm and responsible for suppressing neural
fate. The interesting finding that dissociated ectodermal cells acquired neuronal fate, suggests
that intact tissue and cell-cell contact is necessary to propagate the BMP ligands (Figure 1.1).
The identification of BMPs as neural suppressors prompted the search and discovery of the
suppressor of the suppressors that would promote neural fate. Surprisingly, multiple classes of
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factors secreted by the notochord were found to antagonize BMP signaling and promote neural
fate including noggin, chordin, follistatin, and fibroblast growth factors (FGFs).
In addition to specifying the neural plate, these notochord derived factors induce morphological
changes in the cells abutting the notochord to form median hinge point (MHP) cells in mouse
(Jeong and Epstein, 2003). In chick and zebrafish however, the MHP cells are derived from
Henson’s node, and are of a distinct lineage compared to the surrounding neuroepithelial cells of
the neuroectoderm (Le Douarin and Halpern, 2000; Charrier et al., 2002; Strähle et al., 2004;
Placzek and Briscoe, 2005). The MHP cells become anchored to the notochord and allow for the
folding of the neural plate into the neural tube. Once the neural tube is established, the MHP
cells transform into another organizing center called the floor plate. Upon induction of the floor
plate, the notochord begins to regress and will form the center of the intervertebral discs, as the
floor plate takes over for the next part of development in specifying cell fate. The induction of
new organizing centers in conjunction with tissue growth and development is a theme my thesis
will continue to touch upon.

2

Figure 1.1 Inhibition of bone morphogenetic protein (BMP) signaling initiates neural
induction.
Reproduced from Principles of Neuroscience, (Kandel, E. R., et al., 2012)

3

1.1.2 Formation of the floor plate
The floor plate of the presumptive spinal cord is established when MHP cells encounter another
key morphogen, sonic hedgehog (Shh), secreted by the notochord. Shh signaling regulates
specific transcription factors in series depending on the concentration and duration of exposure
to the Shh ligand. The transcription factors that are activated in response to Shh are referred to as
class II, while the factors that are repressed are class I. These two classes of proteins actively
cross-repress each other, allowing for the sharpening of progenitor domain borders. While the
Shh morphogen gradient begins to be established ventrally, it is met by the opposing BMP
gradient originating dorsally from the roof plate which has been established earlier. As Shh is
secreted from the notochord and reaches the presumptive floor plate, it activates Nkx6.1 and
represses BMP activated Pax6 expression in ventral most recipient cells. Increased Shh ligand
accumulation in the floor plate activates Olig2 expression while shifting Nkx6.1 expression
dorsally. This pattern of sequential activation of Shh target genes continues with the expression
of Nkx2.2 and finally Foxa2 (or HNF3β) in the floor plate, and the shifting of domains induced
by lower concentrations dorsally (Figure 1.2). Once Foxa2 is activated, the floor plate itself
begins to transcribe and secrete Shh to maintain the five established Shh-dependent progenitor
domains and account for neural tube growth.
The floorplate can be divided into two parts, medial (MFP) and lateral (LFP). The MFP is
established first around E7.5 in mouse and will be responsible for inducing the majority of
neuronal cell fates in the developing spinal cord. LFP forms around E12.5 in mouse and E3.5E5.5 in chick and consists of cells that are part of the adjacent Nkx2.2 domain, are induced by
Shh signaling from the MFP (Schauerte et al., 1998; Varga et al., 2001), and begin expressing
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Shh themselves during the onset of oligodendrogenesis (Charrier et al., 2002; Park et al., 2004;
Oustah et al., 2014) (Figure 1.3). The expansion of the floor plate is hypothesized to provide the
additional Shh needed to switch from neuron production to glia (Oustah et al., 2014).

Figure 1.2 Transient expression of Olig2 in the floor plate and p3 domain.
Reproduced from (Ribes and Briscoe, 2009)

5

Figure 1.3 Development of the medial and lateral floor plate.
Adapted from (Charrier et al., 2002)
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1.1.3 Mechanisms of the Shh morphogen gradient
How Shh is released has been a topic of active debate. Since the classical notochord grafting
experiments demonstrated the morphogenic activity of Shh signaling, it was long assumed the
mechanism of gradient formation to be passive diffusion. Transplanted beads soaked in Nterminal Shh ligand were able to induce ventral fates in the early neural tube, supporting the
passive diffusion model (Patten and Placzek, 2002). However, many lines of research in different
developing tissues, in several species, argue against the passive diffusion model. Limitations for
diffusion include scaling with tissue growth and a lack of directional specificity leading to
decreased efficiency since gradients extend in all directions from a source.
Fully processed Shh is post-translationally modified with a cholesterol and palmitate moiety,
making it optimized for membrane association. Several mechanisms of Shh release from the
plasma membrane and/or signaling has been proposed including aid from chaperone binding
proteins like Scub2 (Creanga et al., 2012; Tukachinsky et al., 2012), sequestration into
extracellular vesicles (Zeng et al., 2001; Panáková et al., 2005), or concentration into filopodia
like structures called cytonemes. Cytonemes are long range protruding structures that provide an
alternative to the passive diffusion model and suggest that morphogen gradients like Shh are
established through a mesh of long range filaments extending from signaling and receiving cells
(Figure 1.4). Cytonemes in drosophila, zebrafish, chick, and mouse have been demonstrated to
carry both the receptors and ligands of FGF (Roy et al., 2011; Snyder et al., 2015), Notch (Cohen
et al., 2010; Hamada et al., 2014; Huang and Kornberg, 2015; Eom et al., 2015), TGFβ (Roy et
al., 2014), Wnt (Huang and Kornberg, 2015; Stanganello et al., 2015), Shh (Rojas-Ríos et al.,
2012; Sanders et al., 2013; Bischoff et al., 2013), and more, demonstrating a highly conserved
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developmental process. Morphogen gradients established through “cytoneme synapses” are able
to better explain the continued maintenance of a gradient with increasing growth and complex
tissue volume which hinders the diffusion model, by growing the cytonemes in conjunction with
the rest of the tissue. The concept of targeted “hand delivery” of morphogens to their intended
target is an idea that I investigate in this thesis.
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Figure 1.4 Mechanism of gradient formation and maintenance through cytonemes.
Reproduced from (Bischoff et al., 2013)
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1.1.4 Sonic hedgehog pathway
Shh signaling can be read out in several pathways, transcription-dependent and -independent,
depending on the subcellular localization of the Smo receptor (Bijlsma et al., 2012). Activation
of the canonical transcription dependent pathway is dependent on the primary cilia and is
associated with proliferation and differentiation programs, while activation of the transcription
independent pathway has been shown to be involved in chemotaxis and cytoskeletal
rearrangement and does not require a primary cilium. Both of these pathways act through the
Ptch and Smo receptors, but only the canonical transcription dependent response signals through
the glioma-associated oncogene zinc finger transcription factors Gli1, 2, and 3 which are
modified into activator or repressor forms in a context dependent manner and act on the
transcription of Shh target genes. In the absence of Shh ligand, Ptch inhibits Smo allowing
downstream Gli processing to generate Shh transcriptional repressors. Upon binding of Shh to
Ptch, Smo is un-inhibited, translocated into the primary cilium, and allows the processing of Gli
transcriptional activators. Activator forms of Gli lead to the transcription of Shh target genes
including Ptch, forming a negative feedback loop that restricts Shh signaling both spatially and
temporally.
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Figure 1.5 Sonic hedgehog signaling pathway.
Reproduced from (Fernandes-Silva et al., 2017)
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1.1.5 Neural tube neurogenesis
The neural tube can be broadly divided into dorsal and ventral halves that consist of naive neural
progenitors that await instruction to differentiate into specific cell types. Neurogenesis occurs
from embryonic day E9.5 to E12.5, followed by gliogenesis E12.5 to E15.5. The dorsal half
gives rise to interneurons (d1-d6) which are primarily somatosensory, while the ventral half
gives rise to motor neurons (MNs) and interneurons (V0-V3) involved in motor control. These
classically identified neuronal subtypes are now beginning to be dissected to reveal a much
greater complexity. For example, Bikoff et al. and Gabitto et al. have demonstrated there to be at
least 50 unique subtypes of V1 interneurons (INs) alone. It is unclear if all neuronal subtypes are
specified by the intersection of morphogen gradients during neural tube patterning or acquire
their final identity once they are integrated into a circuit.
The fate of ventral V0-V3 INs and MNs requires precise Shh signaling as demonstrated in both
in vivo and in vitro experiments, with the actual concentration identified to induce each neuronal
type (Ericson et al., 1997). V3 INs originate from the Nkx2.2 domain, MNs from Olig2, V2 INs
from the dorsal boundary of Nkx6.1, V1 INs from the ventral boundary of Dbx2, and V0 INs
from the Dbx1 domain. The maintenance and expression of each transcription factor domain by
sustained Shh signaling is essential for generating correct numbers of neurons. In Pax6-/mutants, the Nkx2.2 domain expands dorsally, characteristic of increased Shh signaling (Ericson
et al., 1997). While in Nkx2.2-/- mutants, V3 INs are not generated and the MN generating Olig2
domain expands ventrally (Briscoe et al., 1999).
Interestingly, not only is concentration important in specifying the correct progenitor domains,
but duration of signaling as well. V0-V2 INs are specified after the more ventral domains and
12

therefore receive less Shh signaling both in concentration and duration. In vitro differentiation of
V0-V2 INs is achieved only when exposed to less than 18 hours of Shh ligand, further exposure
leads to more ventral fates (Dessaud et al., 2010). For ventral domains like Olig2, continued
exposure to Shh is required to maintain expression, and inhibition of signaling reverts to an
antecedent identity. Surprisingly, the Olig2 domain and not the more ventral Nkx2.2, remains the
most sensitive to any disturbance in duration or concentration of Shh signaling (Dessaud et al.,
2010; Yu et al., 2013), suggesting a non-uniform regulation in morphogen gradient readout,
consistent with the cytoneme model of morphogen action.

13

Figure 1.6 Early induction and patterning of Shh dependent domains.
Reproduced from (Ribes and Briscoe, 2009)
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1.1.6 Motor neuron development
Motor neurons (MNs) are among the first neurons to be generated in the vertebrate neural tube.
The MN lineage can be traced back to the progenitor Olig2 or pMN domain. MNs begin to
migrate out of the ventricular zone around E9.5 and initiate terminal differentiation while
heading to the ventral horns of the developing spinal cord. MN generation lasts for
approximately 3 days before the pMN domain switches to OPC production. Many signaling
cascades have been described that are involved with specifying MN cell fate. Some of the most
extensively characterized factors are Olig1 and Olig2. Although Olig2 expression is obligatory
for specifying MN fate in progenitors, Olig2 actually represses the expression of genes involved
in post-mitotic MN differentiation like Hb9 (Lee et al., 2005), and therefore acts to maintain the
pMN progenitor domain. How are MNs then produced if their progenitors express antidifferentiation factors like Olig2? Transcription factors Olig1 and Olig2 induce the expression of
Ngn2 (neurogenin 2) which is critical for MN cell fate acquisition (Zhou et al., 2001; Novitch et
al., 2003), and the antagonistic function of Olig2 is counterbalanced by Ngn2, creating a
negative-feedback loop. This relationship was found by Pfaff and colleagues when they
discovered that MN progenitors express heterogenous levels of Olig2 and Ngn2, hypothesizing
that this process allows a subset of progenitors to differentiate into MNs while leaving others for
oligodendrocyte fate (Lee et al., 2005). The idea that MNs and oligodendrocytes are produced
from the same progenitor population is still a topic of active debate which is the topic of the next
section of this thesis.

Besides the acquisition of a “general” MN fate, MNs are further specified into columns that are
determined by Hox genes. Hox genes are a highly conserved class of transcription factors that
15

are responsible for patterning the rostral to caudal body axis in many organisms. Hox gene
expression marks the delineation between the different segments of the spinal cord and
hindbrain, and ablation of any Hox genes results in deletion, disorganization, or ectopic
conversion of MN column identity (Philippidou and Dasen, 2013). The rostro-caudal axis of Hox
gene expression, similar to the dorso-ventral axis of neuronal specification described above, is
induced by morphogen activity. Retinoic acid secreted by rostrally located somites induce rostral
Hox gene expression, while FGFs secreted caudally from the node induce caudal Hox genes
expression.

16

Figure 1.7 Motor neuron column organization throughout the rostral-caudal axis.
Reproduced from (Butler and Bronner, 2015)
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1.1.7 Motor neuron - oligodendrocyte “switch”
The first non-neuronal cell type to differentiate after neurons from the ventricular zone of the
spinal cord are oligodendrocyte precursor cells (OPCs). OPCs are the source of mature
oligodendrocytes in the CNS. Ventral OPCs (vOPCs) arise from the pMN domain at E12.5 after
MNs have terminally differentiated and migrated out of the ventricular zone (Pringle and
Richardson, 1993; Timsit et al., 1995; Orentas and Miller, 1996). Oligodendrocytes like MNs
require Olig2 function, and both populations are lost in Olig2 null animals (Lu et al., 2002;
Takebayashi et al., 2002; Zhou and Anderson, 2002). Whether OPCs come from the same Olig2
pMN progenitors that first generated MNs is still an open question.
Evidence supporting a common progenitor model stems from the finding that phosphorylation of
Olig2 at serine 147 promotes MN identity while dephosphorylation at the same residue switches
in vivo mouse and chick pMN neural progenitors to adopt OPC fate (Li et al., 2011).
Additionally, delta-notch signaling in zebrafish pMN precursors is required for OPC
specification by inhibiting pro-neuronal genes and if perturbed maintain a neuronal fate and
continue producing MNs (Park and Appel, 2003). The studies aforementioned demonstrated the
ability of MNs to be ectopically generated at the cost of OPCs, interestingly the Becker group
additionally demonstrated the plasticity of the zebrafish pMN domain to revert to MN production
during oligodendrogenesis by genetically ablating post mitotic MNs (Ohnmacht et al., 2016),
suggesting the fate of pMN precursors is quite plastic even in vivo.
An alternative model is the heterogeneous progenitor model proposed by observations in live
zebrafish embryos where OPC progenitors arise from a distinct population of NSCs that descend
from dorsal domains ventrally to the pMN domain (Ravanelli and Appel, 2015). Additional
18

support for the heterogenous progenitor model comes from experiments which ablated pMN
progenitors using Olig1 driven diphtheria toxin and found that although all MN progenitors were
lost, Olig2+ OPC progenitors were still generated at E12 (Wu et al., 2006), these OPCs were
likely generated from either neural stem cell (NSC) precursors within the pMN domain or
migrating NSCs from other domains, suggesting distinct progenitors for MNs and
oligodendrocytes. In further support of progenitors dropping down from dorsal domains into the
pMN, Dessaud et al., genetically labeled cells that arise from the dorsal Dbx1 domain and found
that some of these cells were found within the pMN domain right before the onset of vOPC
production (Dessaud et al., 2010). This observation is in support of the idea that the pMN
domain initially generates MNs and then NSCs from dorsal domains (Dbx1) migrate down into
the pMN domain to repopulate and replenish the pMN domain as more MNs are generated and
migrate out. This process continues into vOPC generation, with additional NSCs migrating
ventral and adopting pMN fate and Olig2 expression. The plasticity of progenitor cells within the
pMN domain has also been demonstrated in vitro by their bipotential potential to become MNs
or OPCs, depending on the intersection of many signaling factors.
vOPCs similarly to MNs, require Shh signaling for their generation as demonstrated by
numerous gain- and loss- of function experiments in both chick and mouse embryos (Orentas and
Miller, 1996; Pringle et al., 1996; Richardson et al., 1997; Orentas et al., 1999; Lu et al., 2000).
Interestingly, not only is Shh necessary to maintain Olig2 expression in the pMN domain, but the
migration of dorsal NSCs into the pMN domain also requires Shh signaling (Ravanelli and
Appel, 2015). In contrast to MNs, vOPC generation requires higher concentration of Shh
signaling (Danesin et al., 2006). Increased concentration of Shh signaling to the Olig2 domain at
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E12.5 is observed by an interruption of the linear decreasing gradient of Ptch mRNA expression
with increased signal around the Olig2 domain (Danesin et al., 2006).
One proposed mechanism leading to an increase of Shh concentration to the Olig2 domain is
through regulation of extracellular glycosaminoglycans (GAGs) and heparin sulfate proteoglycan
(HSPG) chains by sulfatases that “uncage” Shh ligand. Extracellular regulation of morphogen
ligands have been studied in the drosophila developing wing where HSPGs transport and prevent
the degradation of the Shh homologue, Hedgehog, and participate in sculpting the morphogen
gradient (Han et al., 2004; Carrasco et al., 2005). Several studies suggest Shh preferentially binds
to HS chains having high levels of sulfation (Carrasco et al., 2005; Dierker et al., 2009; Zhang et
al., 2007). Sulfatases Sulf1 and Sulf2 have been implicated in regulating the increase of Shh
signaling necessary to transition from MN to OPC production in the neural tube of zebrafish,
chick, and mice, presumably by lowering the interaction of Shh and HSPGs and allowing for
more available Shh ligand (Danesin et al., 2006; Touahri et al., 2012; Oustah et al., 2014; Jiang
et al., 2017). Knockout of Sulf1 or Sulf2 reduces the Shh concentration to the Olig2 domain as
visualized by ptch1 and gli1 in situ expression and prolongs MN generation at the expense of
oligodendrocytes (Touahri et al., 2012; Jiang et al., 2017). Additionally, knockout of the
GlcNAc6ST-1 gene which is necessary for Keratin sulfate (KS) chain elongation, mirrored the
phenotype of the sulfatase studies, suggesting that KS may capture Shh that is released from the
Sulf1 modified heparan sulfate and to transmit Shh signaling to the pMN domain, providing
additional support for Shh morphogen regulation by extracellular GAG and HSPG chains
(Hashimoto et al., 2016).
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The necessary Shh source for vOPC development has been long attributed to the MFP as vOPCs
fail to develop in animals where Shh has been ablated with Foxa2-Cre, Nkx2.2-Cre, and Brn4Cre, all of which are active in the MFP (Dessaud et al., 2010; Yu et al., 2013). Sulf1, Sulf2, and
KS all display expression patterns of highest intensity in the MFP, Nkx2.2, and Olig2 domains.
Evidence points to a role for sulfatases contributing to boosting Shh signaling to the Olig2
domain, and in the absence of Sulf1 or Sulf2, MNs continue to be generated during the time of
vOPC production, seemingly because of reduced Shh signaling. However, interestingly there are
equal numbers of Olig2 progenitors in the pMN domain of Sulf1 mutants and Sulf2 mutants
compared to controls at E12.5, suggesting that there is enough Shh present to maintain Olig2
expression in the pMN domain at this time (Touahri et al., 2012; Hashimoto et al., 2016; Jiang et
al., 2017). However, Sox10 expression, one of the earliest markers for the specification of OPCs,
is reduced in Sulf mutants at E12.5 (Touahri et al., 2012). These results suggest that sulfatases
are not necessary for the maintenance of Olig2 expression in pMN precursors but are required
for the specification of pMN precursors to become vOPCs, and in the absence of Sulf1 or Sulf2,
MNs continue to be ectopically produced.
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1.2 Oligodendrocyte precursor development
1.2.1 Oligodendrocytes and oligodendrocyte precursors

Oligodendrocytes are a unique class of glia that have the ability to wrap and insulate neuronal
axons with their specialized membrane allowing for significantly increased rate of saltatory
conduction of action potentials. Additionally, their intimate relationship with axons provides
trophic support to neurons, such as a source of lactate which will lead to the generation of ATP,
that is critical for the high metabolic demand of neurons. Most oligodendrocytes arise from the
terminal differentiation of OPCs during early post-natal life but adult resident OPCs maintain the
potential to generate new oligodendrocytes throughout life in mice and humans (Yeung et al.,
2014; Tripathi et al., 2017). Production of new oligodendrocytes was shown to be necessary for
motor learning tasks in mice (Sampaio-Baptista et al., 2013; McKenzie et al., 2014; Xiao et al.,
2016), demonstrating the dynamic regulation of these cells in response to environmental stimuli.

Many neurodegenerative diseases such as multiple sclerosis (MS) (Chang et al., 2000) and
amyotrophic multiple sclerosis (ALS) (Kang et al., 2013; Ferraiuolo et al., 2016) implicate
oligodendrocyte or OPC dysfunction as a core determining factor of disease onset or severity. Of
particular interest, Bergles group demonstrated that in the murine G93A familial ALS model,
PCs turnover rate is drastically increased specifically around dying MNs (Kang et al., 2013).
Whether MN death is a consequence or cause of OPC dysfunction in the G93A mouse model is
still unknown, however deletion of mutant SOD1G93A in OPCs using Pdgfra-Cre delayed disease
onset in mice with a SOD1G93A background (Kang et al., 2013), indicating OPCs definitely have
a role to play.
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1.2.2 First wave of ventral spinal cord oligodendrocyte precursors

OPCs were the last “major” glial class to be described in 1921 by Rio-Hortega, then called
oligodendroglia, using classical silver carbonate staining. In the 1990s, OPCs were found to
express the markers neural/glia antigen 2 (NG2) (Levine et al., 1993) and platelet-derived growth
factor alpha receptor (Pdgfra) (Pringle et al., 1992). Shortly thereafter in situ hybridization and
antibodies confirmed the initial development of ventral OPCs in rat and mouse (Pringle and
Richardson, 1993; Yu et al., 1994; Nishiyama et al., 1996; Hall et al., 1996; Pringle et al., 1996)
and determined that as soon as OPCs are specified and migrate out of the ventricular pMN, they
begin expressing OPC markers such as NG2 and Pdgfra, while retaining Olig2 and Sox10
expression.
Upon exiting the pMN domain, OPCs contact the vasculature and migrate along vessels as they
spread throughout the spinal cord (Tsai et al., 2016). These same vessels were earlier
demonstrated to be sculpted by vascular endothelial growth factor (VEGF) signaling from MNs
(Himmels et al., 2017), suggesting an indirect developmental link between MNs and vOPCs. The
first vOPCs to exit the pMN domain, termed pioneer vOPCs, migrate along blood vessels
towards the MNs in the ventral horns where they make synapses with glutamatergic and
GABAergic axons (Osterstock et al., 2018). These synapses receive presynaptic input from
cholinergic MNs that potentiate the frequency of postsynaptic currents with spontaneous
neuronal activity which begins during this time (Hanson and Landmesser, 2003). These results
suggest that OPCs are instructed to initiate gliogenesis in response to a checkpoint of functional
neuronal circuitry in the developing spinal cord and specifically implicates a close association of
MNs with OPC development.
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Oligodendrogenesis, similar to many developmental programs, occurs in a rostral to caudal wave
in the vertebrate spinal cord (Hajihosseini et al., 1996; Novitch et al., 2003; del Corral et al.,
2003). Cervical segments initiating OPC specification and migration first followed by brachial,
thoracic, and lumbar segments following suit. With this developmental mechanism, rostral spinal
segments are developmentally more mature than caudal spinal segments.
Between E12.5 to E14.5 vOPCs migrate out of the ventricular pMN domain and rapidly
proliferate to populate the entire spinal cord. vOPCs will account for ~80% of the total OPCs and
oligodendrocytes of the mature spinal cord, the remaining 20% will be generated from dorsally
derived OPCs (dOPCs) starting at E14.5 (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al.,
2005; Tripathi et al., 2011; Zhu Qiang et al., 2011; Crawford et al., 2016).
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Figure 1.8 Development of multiple waves of oligodendrocyte precursor cells in the CNS.
Reproduced from (Richardson et al., 2006)

25

1.2.3 Second wave of dorsal spinal cord oligodendrocyte precursors

The discovery of a second population of oligodendrocyte precursors in the developing spinal
cord was first found using classical chick – quail transplantation experiments (Cameron-Curry
and Le Douarin, 1995). These findings were later confirmed simultaneously by two independent
groups that found in the mouse spinal cord dorsal dOPCs were derived from a dorsal progenitor
domain several days after the first wave of vOPCs, in a Shh-independent manner (Cai et al.,
2005; Vallstedt et al., 2005). These dOPCs expressed the same markers, Olig1/2, Pdgfra, NG2,
Sox10, as their ventral counterparts, and therefore became indistinguishable as they migrated and
intermingled with vOPCs.

To determine if dOPCs could populate the entire spinal cord in the absence of earlier born
vOPCs, Cai et al., and Vallestdt et al. generated Nkx6.1 and Nkx6.2 double homozygous null
embryos in which vOPCs failed to be generated. Despite the loss of vOPCs, dOPCs were still
generated at E14.5-E15.5 from within the dorsal Pax7 domain and by E18.5 have spread to
ventral parts of the spinal cord. The generation of dOPCs was demonstrated to be Shh
independent by culturing dorsal chick spinal cord explants in the presence of an anti-Shh
antibody, in addition to the finding that Olig2+ OPCs could be identified from Smo-/- ES cell
cultures, as well as in Shh-/- null embryos starting at E14.5 and expanding significantly
throughout the spinal cord by E18.5.

The next breakthrough in distinguishing dOPCs from vOPCs was done by Richardson’s group
with the generation of the oligodendroglia lineage conditional Sox10GFP/tdTomato dual reporter line
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(Tripathi et al., 2011). By crossing this dual reporter line with Msx3-Cre, which overlaps with
the Pax7 domain, Tripathi et al., were able to lineage trace OPCs from both the ventral and
dorsal lineage. The electrical properties, as analyzed by whole cell patch clamping, were found
to be similar between vOPCs/dOPCs and their oligodendrocyte derivatives, vOLs/dOLs.
However, while vOPCs and vOLs were found throughout the entire spinal cord, dOLs were
spatially restricted to the dorsal lateral white matter and dorsal funiculus (DF).

A small (~5%) but notable sub population of dOPCs was shown to transdifferentiate at E15.5
from radial glia of the dorsal Dbx1 domain into OPCs (Fogarty et al., 2005). These dOPCs were
found to occupy the lateral funiculus in post-natal animals, consistent with the location of dOPCs
derived from the Msx3 domain. Since the Dbx1 domain lies within the Msx3 domain, these
dOPCs are likely a subset of dOPCs labeled by Richardson’s Msx3-Cre; Sox10GFP/tdTomato line,
suggesting that the dOPC population itself may be heterogenous.
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1.2.4 Brain oligodendrocyte precursor populations

Unlike the spinal cord, in the forebrain OPCs develop from three domains, Nkx2.1, Gsh2, and
Emx1 (Kessaris et al., 2006). OPC development from the ventral most domain, Nkx2.1 of the
medial ganglionic eminence (MGE) and anterior entopeduncular area (AEP), is comparable to
vOPCs from the pMN in the spinal cord both in onset (E12.5) and strong dependence on Shh
signaling. Second wave OPCs are generated from the more dorsal Gsh2 domain of the lateral
and/or caudal ganglionic eminences (LGE and CGE) around E15.5. The dependence of the Gsh2
second wave OPCs on Shh is somewhat not clear. While the expression of Gsh2 itself depends
on Shh signaling (Sousa and Fishell, 2010), Gsh2 is also a negative regulator of OPC fate, and
only when it is down regulated OPCs are specified (Corbin et al., 2003; Chapman et al., 2013).
The third wave of OPCs arising from most dorsal origins expressing the cortical Emx1 promotor
at E17.5 have been associated as being generated in an Shh-independent manner due to three
findings, 1) OPCs can be generated in tissue cultured from Shh-/- null embryos (Nery et al.,
2001), 2) a FGF2 and Shh-independent mechanism allows for the generation of OPCs in the
cultured dorsal telencephalic tissue (Kessaris et al., 2004), and 3) there is no apparent local
source of Shh in the dorsal telencephalon during third wave OPC generation. While the first two
results suggest that FGF signaling alone can induce low levels of OPCs in the telencephalon, the
cooperation of the FGF and Shh pathways has been demonstrated to result in maximal induction
of OPCs (Kessaris et al., 2004).

But what about the source of Shh that is supposedly acting on Emx1 OPC generation? To answer
this question Winkler et al., used a series of Cre drivers to ablate Shh expression throughout the
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forebrain (Winkler et al., 2018). With Nestin-Cre targeting all midline derivatives of the CNS,
cortical Emx1 OPCs were significantly reduced but not completely ablated, consistent with the
possibility of an inefficient Shh-independent mechanism. To further dissect the source of Shh
necessary for these OPCs the Emx1-Cre, Dlx5/6-Cre, and Cux2-Cre drivers were used. Emx1Cre targeting all precursors of the cortex, Dlx5/6 targeting the subpallium (LGE and MGE)
precursors, and Cux2-Cre targeting the choroid plexus and subpallium. Emx1-Cre driven
ablation of Shh showed no differences in OPC generation in the cortex, suggesting no local Shh
source, however Dlx5/6-Cre or Cux2-Cre driven ablation reduced cortical OPC generation with
similar levels as Nestin-Cre ablation. These experiments therefore identified the necessary Shh
sources for third wave Emx1 OPCs to be migrating GABAergic interneurons from the
subpallium which express Shh on their way to the neocortex in addition to the choroid plexus
which secretes Shh into the ventricles. These results provide evidence of Shh signaling from post
mitotic neurons influencing the generation of OPCs in the developing telencephalon, a theme
that my work also parallels in the spinal cord.
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1.2.5 Functional differences between oligodendrocyte lineages

If OPCs are born in different domains and during different developmental times in the CNS, does
this suggest that they are different populations with functional differences? RNA-seq
experiments identified that there are at least 12 distinct populations of cells in the adult CNS that
were previously associated with being a homogeneous group of OPCs and oligodendrocytes
(Marques et al., 2016). Whether transcriptional heterogeneity among OPC and oligodendrocyte
populations is assigned by developmental origin or through interaction and integration with
specific circuits or CNS regions is still not clear. To determine if the distinct populations were
representative of lineage or rather of current “state”, in a follow up study Marques et al.
performed RNA-seq on OPCs and oligodendrocytes that were labeled with GFP by PdgfraCreERT2 at E13.5 for first wave vOPCs or P7 to label OPCs of all origins (Marques et al., 2018).
This study suggested that the several waves of OPCs that are generated from different domains
and developmental times result in a transcriptionally convergent population of OPCs. However,
the labeling method used by the authors to target ventral and dorsal OPC populations may have
not been selective enough to eliminate contamination between these populations. Due to the lack
of discriminating markers of OPCs from different lineages and the intermingling of OPC
populations throughout the CNS, RNA-seq experiments to date have not shown conclusive gene
expression differences between OPCs of different lineages.

More definitive evidence of functional heterogeneity between different OPC lineages has been
demonstrated by performing demyelination injury in mice with genetic lineage tracing of OPCs
(Zhu Qiang et al., 2011; Crawford et al., 2016). Lysolecithin induced demyelination of the
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ventral white matter induced the preferential remyelination of the injury site by differentiating
dOPCs identified by genetic labeling using Pax3-Cre and a conditional GFP allele as well as
immunolabeling with Olig2 (Zhu Qiang et al., 2011). A similar result was found by Crawford et
al., using the more specific oligodendrocyte lineage conditional allele Sox10GFP/tdTomato in
conjunction with Msx3-Cre to selectively label both vOPCs and dOPCs (Crawford et al., 2016).
Additionally, age-associated differences in responding to demyelination were identified
demonstrating that while dOPCs are preferentially recruited and have a higher differentiation rate
than vOPCs in young animals, in aged animals dOPCs were still preferentially recruited but their
ability to differentiate into mature oligodendrocytes was reduced compared to vOPCs (Crawford
et al., 2016). These results suggest that dOPCs are able to spread to ectopic areas in situations
that result in the absence of vOPCs. The preference of dOPCs to differentiate into mature
oligodendrocytes more so than vOPCs may suggest that vOPCs serve other non-differentiative
roles in the CNS.
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1.3 Introduction to thesis and gaps in the field

Oligodendrocyte precursor cells (OPCs) are the most abundant proliferating cell type in the adult
central nervous system (Horner et al., 2000; Dawson et al., 2003) and are highly mobile (Hughes
et al., 2013). OPCs give rise to myelinating oligodendrocytes (OL) and tile the entire central
nervous system (CNS) without discernable pattern (Dawson et al., 2003). OPCs are activated in
response to demyelination (Levine and Reynolds, 1999; Tripathi et al., 2010; Zawadzka et al.,
2010; Zhu Qiang et al., 2011; Moyon et al., 2015; Crawford et al., 2016) and altered function and
distribution of OPCs have been observed in neurodegenerative (Kang et al., 2013) and
psychiatric diseases (Birey et al., 2015). However, difficulties in determining the ontogenetic
complexity and presumed functional heterogeneity of the OPC population remains a significant
barrier to devising OPC based clinical translations.

The origin of OPCs in the spinal cord can be traced back to ventral (Olig2- expressing) pMN
domain generating vOPCs (Pringle and Richardson, 1993; Timsit et al., 1995; Orentas and
Miller, 1996) or dorsal (Msx3- expressing) precursor domains generating dOPCs (Cai et al.,
2005; Fogarty et al., 2005; Vallstedt et al., 2005; Tripathi et al., 2011; Zhu Qiang et al., 2011). In
the spinal cord, the pMN generates 80% of all postnatal OPCs between E12.5 and E14.5 in a
sonic hedgehog (Shh) signaling dependent manner (Poncet et al., 1996; Orentas and Miller,
1996; Pringle et al., 1996; Richardson et al., 1997; Orentas et al., 1999; Lu et al., 2000) while the
dorsal domain begins to generate the remaining 20% around E14.5 in an apparent Shh signaling
independent manner (Chandran et al., 2003; Cai et al., 2005; Fogarty et al., 2005). OPCs
populate the spinal cord in patterns that over time erode by a progressive replacement of early
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born OPCs with late born OPCs (Kessaris et al., 2006; Tripathi et al., 2011; Zhu Qiang et al.,
2011), leaving unanswered questions about the nature and purpose of the staggered production
and the unique functions of different oligodendrocyte lineages.

OPC lineage specific functions might become more readily apparent by the selective ablation of
the phylogenetically oldest oligodendrocyte lineage, the earliest and ventral born vOPCs of the
spinal cord since early born OPCs might influence distribution and development of later born
OPCs. However, the selective ablation of vOPCs in the spinal cord has so far not been achieved
without also disturbing ventral spinal cord development and, in particular, inhibiting the
developmentally earlier production of motor neurons from the same precursor domain, causing
embryonic lethality (Cai et al., 2005; Vallstedt et al., 2005; Yu et al., 2013) and making it
difficult to assess vOPC function.

vOPCs emerge from the pMN precursor domain, one of five precursor domains that are
established and then maintained along the ventral midline of the developing neural tube in
response to a gradient of Shh signaling activity (Gritli-Linde et al., 2001; Chamberlain et al.,
2008). First, graded Shh signaling originating from the notochord, a tissue organizer at the
ventral midline, imparts spatial information by inducing distinct transcriptional programs in
overlying, naïve neural ectoderm cells in a concentration dependent manner that leads to the
establishment of the V3, pMN, V2, V1 and V0 precursor domains along the ventral to dorsal axis
of the developing neural tube (Dessaud et al., 2008; Alaynick et al., 2011). Subsequently,
persistent Shh signaling originating from the floorplate (FP) located at the ventral midline of the
developing neural tube is critical for maintaining the distinct molecular identities of each of these
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precursor domains throughout the periods of first neurogenesis and then gliogenesis (Dessaud et
al., 2010). The Shh gradient emanating from notochord and FP displays a constant decay length
and does not scale with congruent and rapid growth during early spinal cord development
(Cohen et al., 2015). Consequently, all precursor domains with the exception of the most ventral
p3 domain are out of reach of diffusible Shh from midline sources by the time of the switch from
neurogenesis to gliogenesis. Multiple mechanisms have been proposed to contribute to extending
Shh signaling along the ventral to dorsal axis of the midline including increased expression of
Shh by FP proper (Ribes et al., 2010), expanding Shh expression to extra-midline tissue by
forming the lateral FP (LFP, (Charrier et al., 2002; Park et al., 2004)), reducing the Ptc1 receptor
and extracellular matrix mediated “sink” for Shh (Touahri et al., 2012) and increasing the
sensitivity towards Shh signaling of target cells (Cohen et al., 2015). While all of these
mechanisms could contribute to continued Shh signaling distal to the FP, these mechanisms must
lead to a distortion of the initial correlation between physical distance to the FP and Shh
signaling strength in the ventricular zone since sensitive bio-indicators based on expression of
the Shh target genes Gli and Ptc1 record greater Shh signaling strength in the FP distant pMN
precursor domain than in the FP proximal V3 precursor domain at the end of neurogenesis
(Danesin et al., 2006). How the discontinuity of Shh signaling along the ventral to dorsal axis
can be achieved such that increased Shh signaling strength occurs selectively within the pMN
domain at the time of OPCs production is not clear. There are several possibilities including
preferential growth of cytonemes carrying Shh to the pMN domain, increased activity of
enzymes like sulfatases which uncage trapped Shh in the vicinity of the pMN domain, or the
delivery of Shh specifically to the pMN domain by MN dendrites.
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Here we produced a series of mouse lines with different degrees of conditional Shh gene ablation
from the FP and from ventricular zone derivatives during spinal cord development. We find that
extra-midline sources of Shh in the spinal cord proper are critical for the maintenance of the
Olig2 expressing cell population in the pMN domain during the phase of MN production. While
MN development can proceed successfully in the absence of these Shh sources, the exhaustion of
the pMN domain of Olig2 expressing cells and further diminishment during the phase of ventral
OPC production results in the subsequent reduction in ventral OPC production.
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CHAPTER 2:

Shh sources in the developing and adult spinal cord
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2.1 Shh expression in the ventral spinal cord

To examine the contributions of different sources of Shh in the ventral spinal cord to pMN
domain activity at the time of the transition from motor neuron (MN) to OPC production we first
expanded on previous descriptions of Shh expression during spinal cord development
(Oppenheim et al., 1999; Fogel et al., 2017; Danesin and Soula, 2017). We used a gene
expression tracer and conditional loss of function allele of Shh (Shh-nLZC/C, abbreviated ShhC/C)
in which a bicistronic mRNA is transcribed from the un-recombined Shh locus that encodes Shh
and nuclear targeted LacZ (Gonzalez-Reyes et al., 2012). This allele allows the quantification of
the numbers of cells that express Shh and the determination of Shh ablation efficiencies in
response to Cre activity with single cell resolution. This approach reveals developmental stageand spinal level- specific patterns of Shh expression and relative contributions to ventral Shh
production from several distinct cell populations (Figure 2.1A).

At brachial levels at E12.5 we find Shh in all cells of the MFP (defined by co-expression with
FoxA2) (Figure 2.5A), LFP* (defined by co-expression of Nkx2.2) (Figure 2.5C), LFP
(defined by lack of FoxA2 and Nkx2.2, and positioned dorsal to the MFP, flanking the
ventricular zone) (Figure 2.5A), and in 30% of all motor neurons (MNs) of the lateral motor
column (LMC, defined by co-expression with Hb9) (Fig. 2.1A and Fig. 2.5E). In contrast, at
thoracic and lumbar levels at E12.5, we find Shh expression only in MFP, LFP*, and LFP
(Figure 2.1A). Based on numbers of nLacZ+ cells present at E12.5 we estimate that about 57%
of Shh production occurs by MFP, 30% by the collective LFP and 13% by MNs at brachial
levels (Figure 2.1B), while 100% of Shh production occurs by MFP and LFP at thoracic and
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lumbar levels. Expression of Shh from the three major sources overlaps with the developmental
switch of the pMN domain from making MNs to vOPCs. MFP is the only source of Shh for the
majority of MN development, while LFP and MNs begin expressing Shh during vOPC
production (Figure 2.1C). Further analysis of Shh expression in MNs revealed that lumbar LMC
MNs begin to express Shh at E13.5 resulting in a pattern of expression and relative contributions
to ventral Shh production that is qualitatively similar to brachial levels at E12.5 (Figure 2.6A).

By E14.5 medial motor column (MMC) MNs at brachial, thoracic, and lumbar segments begin to
express Shh (Figure 2.2A) in addition to cells flanking the Dbx1 (P0) precursor domain (Figure
2.6B, red arrows). At P20 Shh expression occurs in MNs, V0 cholinergic neurons, other
interneuron populations, and remaining FP cells that become the ventral part of the central canal
at all spinal cord segments (Figure 2.2B and 2.6C). We observe a similar temporal and
segmental pattern of Shh expression in the developing chick spinal cord (Figure 2.3A-C).
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Figure 2.1 Three sources of Shh in the developing spinal cord at E12.5.
(A) X-gal staining of Shh expressing cells of E12.5 control ShhC/C spinal cord sections. Three
sources identified: Medial floor plate (MFP), lateral floor plate (LFP), and motor neurons (MN).
(B) Average numbers of nLacZ expressing cells in MFP (FoxA2+) n=6, LFP (FoxA2- Nkx2.2-)
n=5, LFP* (FoxA2- Nkx2.2+) n=11, and among MNs (Hb9+) n=14. Ventricular zone derived
(VDZ): LFP, LFP*, and MNs. Breakdown percentages of each Shh source relative to total.
Means ± SEM are shown.
(C) Overlap in MN and vOPC generation from pMN domain with the timing of Shh expression
from all sources.
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Figure 2.2 All MNs express Shh starting at E14.5 through adulthood.
(A) Shh expression by MNs along AP axis at E14.5. Immunostaining colocalization of nLacZ
with MN markers Isl1/2 and ChAT. Revealing that thoracic MNs express Shh much later than
brachial and lumbar.
(B) X-gal staining revealing Shh expression pattern throughout AP axis of P20 ShhC/C spinal
cords at brachial, thoracic, lumbar, and sacral segments.
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Figure 2.3 Evolutionary conserved timing and pattern of Shh expression in vertebrate
MNs.
(A) In situ hybridization for Shh in developing chick neural tube demonstrating comparable
timing and pattern of Shh expression by MNs as in mouse.
(B and C) Timeline of Shh expression by MNs in (B) mouse and (C) chick.
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2.2 Shh ablation strategy using multiple Cre lines

To investigate the role of Shh signaling from these Shh sources onto the pMN domain, we
generated a series of mouse lines with conditional and in part overlapping ablation of Shh. We
used ChAT-Cre (ChATShh-/-) to target MNs, Nestin-Cre (NestinShh-/-) to target all Shh expressing
ventricular zone derivatives (VZD: MNs and LFP), and Olig2-Cre (Olig2Shh-/-), to target MNs,
LFP, and MFP. The location of Shh expression and the varied degrees of ablation of Shh at
E12.5 are schematically summarized in (Figure 2.4).

At E12.5 we did not observe Shh recombination in MFP cells in ChATShh-/- mutants. NestinShh-/mutants had a few MFP cells which displayed Cre activity, but this ablation was insignificant
(Figure 2.5A and 2.5B). However, in Olig2Shh-/- mutants the Shh recombination efficiency
among MFP cells in brachial and thoracic spinal segments revealed a significant 44% and 39%
loss resp. (Figure 2.5A and 2.5B). As expected, we found no recombination of Shh in the LFP
or LFP* in ChATShh-/- (Figure 2.5A-D). Consistent with the previous reported expression of
Nestin-Cre in all derivatives of the ventricular zone between E10.5 to E12.5 (Kramer et al.,
2006; Battiste et al., 2007), and transient expression of Olig2-Cre in all derivatives of the
ventricular zone of the pMN domain and ventral to it (Ribes and Briscoe, 2009), we find near
complete (80% and 90% resp.) ablation of Shh from the LFP and LFP* in both NestinShh-/- and
Olig2Shh-/- (Figure 2.5D). At thoracic segments LFP recombination was less efficient at 60% and
72% for NestinShh-/- and Olig2Shh-/- resp., while LFP* recombination was 77% and 94% for
NestinShh-/- and Olig2Shh-/- resp. (Figure. 2.5D). Cre efficiency in MNs was about 80% in
ChATShh-/- and NestinShh-/- mutants, and 98% for Olig2Shh-/- (Figure. 2.5E and 2.5F).
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Figure 2.4 Schematic depicting Shh sources at brachial and thoracic spinal cord segments
and targeted ablation with each Cre mouse line.
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Figure 2.5 Shh ablation from MNs, LFP, and MFP at E12.5.
(A) Immunostaining for nLacZ and FoxA2 on brachial and thoracic segments. Identification of
MFP (FoxA2+ nLacZ+) and LFP (FoxA2- nLacZ+). LFP cells are identified as dorsal to MFP
cells, oriented in tangent to MFP, and expressing lower levels of nLacZ.
(B) Quantification of MFP nLacZ recombination at brachial and thoracic segments for each Shh
source per genotype. Brachial and thoracic segments ShhC/C n=5, ChATShh-/- n=3, NestinShh-/n=3, Olig2Shh-/- n=5. Means ± SEM are shown. One-way ANOVA, Dunnett’s multiple
comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001.
(C) Immunostaining for nLacZ and Nkx2.2 on brachial and thoracic segments. Identification of
LFP (Nkx2.2- nLacZ+) and LFP* (Nkx2.2+ nLacZ+). Arrows point to migrating LFP* Nkx2.2+
nLacZ+ cells.
(D) Quantification of LFP and LFP* nLacZ recombination at brachial and thoracic segments for
each Shh source per genotype. Brachial and thoracic segments ShhC/C n=5, ChATShh-/- n=4-5,
NestinShh-/- n=4, Olig2Shh-/- n=3. Means ± SEM are shown. One-way ANOVA, Dunnett’s
multiple comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001.
(E) X-gal staining and immunostaining for nLacZ and Hb9 on brachial segments.
(F) Quantification of nLacZ recombination in brachial MNs. ShhC/C n=14, ChATShh-/- n=8,
NestinShh-/- n=5, Olig2Shh-/- n=5. Means ± SEM are shown. One-way ANOVA, Dunnett’s
multiple comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001. Scale bars, 50 μm.
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Figure 2.6 Shh ablation from MNs and derivatives of LFP and MFP through continued
development.
(A and B) X-gal staining revealing ablation of Shh at lumbar spinal cord at (A)E13.5, and (B)
E14.5. Arrows point to a dorsal Shh source located near the ventricular zone appearing at E14.5.
(C) X-gal staining of P20 spinal cords revealing loss of Shh expression from MNs and V0
cholinergic interneurons in ChATShh-/-, MNs and descendants of neurons ventral to the pMN
domain in Olig2Shh-/-, and from all neuronal sources in NestinShh-/-.
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We followed the ablation of Shh from MNs, LFP, and MFP through continued development at
E13.5, E14.5, and up to P20 (Figure 2.6). Ablation in MNs is mostly complete by E13.5 in all
mutant animals analyzed but at E13.5 we did observe a few faint nLacZ+ MNs in ChATShh-/mutants (Figure 2.6A). The dorsal population of Shh expressing cells which appears at E14.5 is
unaffected in ChATShh-/- and Olig2Shh-/- animals but is missing in NestinShh-/- (Figure 2.6B).
These dorsal Shh expressing cells begin expressing Shh during the time of dOPC generation at
E14.5 and may be involved in regulating dorsal oligodendrogenesis which has previously been
suggested of being independent of Shh signaling.

Analysis at P20 demonstrated that all mutant genotypes have lost Shh expression in all MNs
(Figure 2.6C). Additionally, Olig2Shh-/- and NestinShh-/- animals have lost expression of a
subpopulation of Shh expressing cells of the ventral central canal. In these mutants the central
canal appears smaller in size, a phenotype previously seen by Yu et al. in late stage embryos with
Shh ablated from the MFP (Yu et al., 2013). V0 cholinergic interneurons which are generated
from the p0 domain during development express Shh, and this expression is lost in ChATShh-/and NestinShh-/- but not in Olig2Shh-/- animals. In control animals, besides V0 interneurons, many
other cells express Shh and based on the size of their nuclei these cells are likely neurons and are
located primarily in laminae V, VI, VII, and X (Figure 2.2B and 2.6C).
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2.3 Early Shh dependent spinal cord patterning

To determine if early neural tube patterning was affected in Olig2Shh-/- and NestinShh-/- embryos
we analyzed Shh ablation from MFP and the patterning of Shh dependent domains at E10.5.
Using a Cre-dependent conditional reporter allele (Figure 2.7A), we find that Olig2-Cre but not
Nestin-Cre is active in the MFP prior to notochord (NC) regression at E10.5 resulting in the
ablation of Shh from 46 ± 5.1% and 8.5 ± 2.8% (n.s.) resp. of FoxA2+ cells (Figure 2.7B and
2.7C). These results reveal that the degree of ablation of Shh from MFP in NestinShh-/- and
Olig2Shh-/- animals is established at the time of MN production and remains fixed. The drastic
loss of Shh expression in the MFP already at E10.5 in Olig2Shh-/- animals prompted us to
ascertain a possible patterning defect along the ventral midline. Consistent with previous reports
that Shh expression by the notochord (NC) is sufficient for the establishment of precursor
domains in the ventral spinal cord (Dessaud et al., 2010; Yu et al., 2013), we find that the
relative location and size of the p3- (marked by Nkx2.2), pMN- (marked by Olig2) and p0(marked by Dbx1) domains are indistinguishable between Olig2Shh-/- and control embryos at
E10.5 (Figure 2.7D-F).
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Figure 2.7 Ablation of Shh from the MFP has no early patterning defects before regression
of notochord.
(A) Detection of Cre activity in Olig2Shh-/- and NestinShh-/- mutants at E10.5 using the conditional
R26mT/mG allele.
(B) GFP co-labeling of Cre activity in addition to a loss of nLacZ from Foxa2+ cells
demonstrates Shh ablation in MFP of Olig2Shh-/- but not NestinShh-/- embryos. Arrows indicate
MFP FoxA2+ cells that have lost nLacZ expression. NC, notochord.
(C) Quantification of recombination frequency of the ratio of Foxa2+ nLacZ+ double positive
cells. ShhC/C n=2, NestinShh-/- n=3, Olig2Shh-/- n=5. Means ± SEM are shown. One-way ANOVA,
Tukey post hoc test. ∗p<0.05, ∗∗p<0.01.
(D) Immunostaining of Shh-sensitive domains, Olig2, Nkx2.2, Dbx1, and Pax6 are unaffected at
E10.5 in Olig2Shh-/-, despite MFP recombination.
(E) Quantification of relative domain sizes and numbers of Nkx2.2, Olig2, Dbx1. Domain
measurement ShhC/C n=4-6, Olig2Shh-/- n=4. Means ± SEM are shown. Cell counts ShhC/C n=5-8,
Olig2Shh-/- n=4-8. Data were analyzed by Student’s t test. ∗p<0.05, ∗∗p<0.01.
(F) Scheme highlighting position of p3 (Nkx2.2), p0 (Dbx-1), and pMN (Olig2) domains relative
to the MFP at E10.5.
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2.4 Thesis Rationale: Part 1- Development of vOPCs

(1) The expression pattern and timing of Shh onset in MNs, LFP, and MFP.

(2) The varied degrees of quantifiable and source selective ablation of Shh from the ventral
spinal cord.

(3) The preservation of early ventral tube patterning.

These results indicated that this set of recombinant mouse lines might be informative in the
investigation of the effect of VZD sources of Shh onto the pMN domain during MN and vOPC
generation.
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CHAPTER 3:

Shh from VZD sources in addition to MFP is critical for pMN
domain maintenance during the onset of gliogenesis in a spinal
level specific manner

51

Previous studies established that Shh signaling from within the spinal cord proper is critical for
the maintenance of established precursor domains after regression of the NC but did not evaluate
the contribution from individual Shh sources (Dessaud et al., 2010; Yu et al., 2013). We
therefore next investigated ventricular zone organization and precursor domain maintenance after
NC retraction in ChATShh-/-, NestinShh-/-, and Olig2Shh-/- embryos. We find that the relative
location and distance to each other of the p3, pMN, and p0 precursor domains are preserved in
ChATShh-/-, NestinShh-/-, and Olig2Shh-/- embryos at E12.5 (Figure 3.1). However, we observe a
Shh source- and dose-dependent, spinal level specific decline in the numbers of Olig2+ cells in
the pMN domain (pMN/Olig2+) of ChATShh-/-, Olig2Shh+/-, NestinShh-/-, and Olig2Shh-/- embryos
compared to ShhC/C or Olig2-Cre control embryos (Figure 3.2A and 3.2B).

In ChATShh-/- embryos we find a 26% decrease in pMN/Olig2+ cells (ShhC/C 63 ± 3.7 cells vs
ChATShh-/- 46.5 ± 5.5 cells) at brachial levels (but not at thoracic or lumbar segments) consistent
with expression of Shh in MNs at brachial but not yet in MNs at thoracic and lumbar levels at
E12.5 (Figure 3.2B). Upon more detailed analysis, we find the effect of MN Shh to be most
pronounced during the enlargement of the pMN at brachial segments between E12.5 to E12.75
(Figure 3.2C and 3.2D). The numbers of pMN/Olig2+ cells in NestinShh-/- embryos displays an
anterior-posterior progressive decrease of 40% at brachial (ShhC/C 63 ± 3.7 cells vs NestinShh-/- 38
± 6.4 cells), 51% at thoracic (ShhC/C 51 ± 2.5 cells vs NestinShh-/- 25 ± 3.4 cells) , and 59% at
lumbar segments (ShhC/C 46 ± 3.3 cells vs NestinShh-/- 19 ± 5.0 cells) (Figure 3.2B).
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Figure 3.1 The pMN domain is particularly sensitive to reduced Shh signaling at E12.5.
Immunostaining of nLacZ with Nkx2.2, Dbx-1, and Olig2 on E12.5 thoracic sections.
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Figure 3.2 Shh from LFP and MNs in addition to MFP is critical for pMN domain
maintenance in a spinal level specific manner.
(A) Immunostaining for Olig2 in the pMN domain along the AP axis on brachial, thoracic, and
lumbar sections for ShhC/C, ChATShh-/-, NestinShh-/-, Olig2-Cre, Olig2Shh+/-, and Olig2Shh-/-.
(B) Quantification of numbers of Olig2 cells in the pMN domain for brachial, thoracic, and
lumbar sections. Means ± SEM are shown. ShhC/C n=12, Olig2-Cre n=2, ChATShh-/- n=6,
Olig2Shh+/- n=5, NestinShh-/- n=4, Olig2Shh-/- n=8. One-way ANOVA, Dunnett’s or Tukey’s
multiple comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001.
(C) Expansion of pMN domain at onset of gliogenesis at brachial segments between E12.25E12.75.
(D) Quantification of Olig2 cells in the pMN domain on brachial segments. Means ± SEM are
shown. E12.25 ShhC/C n=3, ChATShh-/- n=3, E12.50 ShhC/C n=3, ChATShh-/- n=3, E12.75 ShhC/C
n=3, ChATShh-/- n=3. Data were analyzed by Student’s t test. ∗p<0.05.
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The most severely affected genotype is Olig2Shh-/- with a decrease in pMN/Olig2+ cells of 66% at
brachial (ShhC/C 63 ± 3.7 cells vs Olig2Shh-/- 21 ± 4.7 cells), 61% at thoracic (ShhC/C 51 ± 2.5 cells
vs Olig2Shh-/- 20 ± 3.2 cells), and 72% at lumbar segments (ShhC/C 46 ± 3.3 cells vs Olig2Shh-/- 13
± 3.2 cells ) (Figure 3.2B). Olig2Shh+/- embryos exhibit a decrease of pMN/Olig2+ cells of 37%
at thoracic (ShhC/C 51 ± 2.5 cells vs Olig2Shh+/- 32 ± 3.4 cells) and 26% at lumbar (ShhC/C 46 ±
3.3 cells vs Olig2Shh+/- 34 ± 2.9 cells), with no measurable reduction in numbers of pMN/Olig2+
cells at brachial levels (Figure 3.2B).

We next associated the degree of reduction in the numbers of pMN/Olig2+ cells at brachial and
thoracic levels with the time of onset and tissue specific efficiency of Shh ablation in ChATShh-/-,
Olig2Shh-/-, and NestinShh-/- embryos (Figure 3.3). In control animals we find about 19% (brachial
63 ± 3.7 cells vs thoracic 51 ± 2.5 cells) more pMN/Olig2+ cells at brachial than thoracic
segments. The 80% efficient ablation of Shh from MNs in ChATShh-/- reduces the numbers of
pMN/Olig2+ cells at brachial levels to those present in controls at thoracic levels while the
ablation of Shh from MNs has no effect on the numbers of pMN/Olig2+ cells at thoracic levels
(Figure 3.3, red line). NestinShh-/- and Olig2Shh-/- embryos exhibit near complete ablation of Shh
from MNs and LFP, but significantly different ablation efficiencies in the MFP, resulting in a
reduction of pMN/Olig2+ cells at brachial levels that scales with the degree of Shh ablation from
the MFP. At thoracic levels, however, we find the same magnitude in the reduction of the
numbers of pMN/Olig2+ cells in NestinShh-/- and Olig2Shh-/- embryos despite of a much greater
total reduction in numbers of Shh producing cells by Olig2-Cre compared to
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Figure 3.3 Association of source specific Shh ablation with Olig2 pMN size.
Schematic representing Shh ablation within the genotypes and associated numbers of average
Olig2 cells for brachial and thoracic sections.
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Nestin-Cre. This observation suggests that Shh produced by LFP cells, though few in number,
has a disproportionate significance compared to MFP derived Shh for pMN/Olig2+ cells at
thoracic segments.

Next, we determined if the decreased numbers of pMN/Olig2+ cells is the result of diminished
initial specification or a failure of the maintenance. We lineage traced Olig2 cells in Olig2Shh-/mutants, Olig2Shh+/- and Olig2-Cre controls, using the R26mT/mG reporter allele from which
myristylated GFP is expressed in all derivatives of Olig2 expressing cells and immunostained for
Olig2 at E12.5 (Figure 3.4). We observe GFP expression in the ventral spinal cord forming a
dorsal boundary at a similar relative distance to the MFP in mutants and controls but a decline in
Olig2+ GFP+ double positive cells in the pMN domain in mutants compared to controls. This
data suggests that the pMN was initially correctly specified but is not maintained. Notably, the
absence of Olig2 expressing cells within the GFP labeled area in mutants is most pronounced in
the dorsal half of the pMN domain. Together, these results demonstrate that ongoing Shh
signaling originating is critical for the selective maintenance of pMN/Olig2+ cells once the
influence of notochord Shh has waned.
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Figure 3.4 Active Shh signaling maintains Olig2 expression in the pMN at E12.5.
E12.5 Olig2-Cre lineage tracing in thoracic sections reveals correct establishment of the pMN as
indicated by dorsal boundary of R26mT/mG expression, however failure of maintenance of Olig2
in Olig2Shh-/- animals compared to Olig2Shh+/- and Olig2-Cre.

58

CHAPTER 4:

Shh signaling from MFP, but not VZD sources influences
MN generation

59

We next investigated whether the impoverishment of the pMN domain of Olig2+ precursor cells
impacts MN production. We analyzed columnar pattern, relative distribution of MNs among
columns, and absolute numbers of MNs of different columnar identity at brachial and thoracic
levels. We first visualized MN columnar organization by immunohistochemical stainings for
MMC (Hb9+ Lhx3+), LMCM (Hb9+ Isl1/2+), and LMCL (Hb9+, Isl1/2-, Lhx3-) at brachial
(Figure 4.1A) and MMC (Hb9+, Isl1-), HMC (Hb9+, Isl1/2+), and PGC (Hb9-, nNos+) at
thoracic (Figure 4.1E) and found no apparent differences in the staining pattern either among
ChATShh-/-, NestinShh-/-, Olig2Shh+/- , or Olig2Shh-/- embryos compared to ShhC/C controls. Further
supporting unaffected MN positioning and patterning, we find inconspicuous ventral root
formation in Olig2Shh-/- embryos compared to ShhC/C controls at E10.5 and E12.5. (Figure 4.2A).

Quantification of MN numbers revealed no differences in ChATShh-/- and NestinShh-/- embryos
compared to ShhC/C controls at brachial and thoracic levels. In contrast, in Olig2Shh+/- and
Olig2Shh-/- embryos we find a 22% and 38%, resp. reduction in the numbers of total MNs at
brachial (ShhC/C 152 ± 5.2 cells, Olig2Shh+/- 119 ± 11.7 cells, Olig2Shh-/- 94 ± 1.9 cells) (Figure
4.1B), and 22% and 32% at thoracic levels (ShhC/C 106 ± 2.3 cells, Olig2Shh+/- 83 ± 3.7 cells,
Olig2Shh-/- 72 ± 5.3 cells) compared to ShhC/C controls (Figure 4.1F). Since the production of late
born MNs could be affected to a greater extent than early born MNs by the ablation of Shh from
previously born VZD (i.e. MNs and LFP) we compared the relative size of the MN columns and
the numbers of late born MNs just emerging from the ventricular zone at 12.5. We found that
MNs attained columnar identities in normal relative proportions in all genotypes (Figure 4.1D
and 4.1H).
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Figure 4.1 Shh signaling from MFP, but not LFP or MNs influences MN generation.
(A) E12.5 brachial sections immunostained with Hb9, Lhx3, and Lhx1 to distinguish MMC and
LMCL columns, and Hb9 and Isl1/2 to distinguish LMCM and LMCL columns.
(B) Quantification of total brachial MNs. ShhC/C n=11, ChATShh-/- n=5, NestinShh-/- n=4,
Olig2Shh+/- n=3, Olig2Shh-/- n=5. Means ± SEM are shown. One-way ANOVA, Dunnett’s multiple
comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001.
(C) Quantification of total numbers of MMC, LMCM, and LMCL MNs. Means ± SEM are
shown. One-way ANOVA, Dunnett’s multiple comparison post hoc test. ∗p<0.05, ∗∗p<0.01,
∗∗∗p<0.001.
(D) Ratio of each motor column to total brachial MNs. Means ± SEM are shown. One-way
ANOVA, Dunnett’s multiple comparison post hoc test. NS, not significant, P>0.5.
(E) E12.5 thoracic sections immunostained with Hb9 and nNos to distinguish MMC and HMC
from PGC column, and Hb9 and Isl1/2 to distinguish MMC and HMC columns.
(F) Quantification of total thoracic MNs. ShhC/C n=4-5, ChATShh-/- n=5, NestinShh-/- n=4,
Olig2Shh+/- n=4, Olig2Shh-/- n=5. Means ± SEM are shown. One-way ANOVA, Dunnett’s multiple
comparison post hoc test. ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001.
(G) Quantification of total numbers of MMC, HMC, and PGC MNs. Means ± SEM are shown.
One-way ANOVA, Dunnett’s multiple comparison post hoc test. ∗p<0.05, ∗∗p<0.01,
∗∗∗p<0.001.
(H) Ratio of each column to total thoracic MNs. Means ± SEM are shown. One-way ANOVA,
Dunnett’s multiple comparison post hoc test. NS, not significant, P>0.5. Scale bars, 50 μm.
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Figure 4.2 MN axon anatomy during development and postnatal MN numbers are
unaffected by reduced Shh signaling.
(A) AnkG staining at E10.5 and E12.5 revealing correct MN axon fasciculation and exit from
ventral horns in Olig2Shh-/-.
(B) Lumbar L4-L5 motor neurons are similar in number and organization in all genotypes.
ShhC/C (n = 4 mice), ChATShh-/- (n = 4 mice), NestinShh-/- (n = 3 mice), Olig2Shh-/- (n = 5 mice).
Means ± SEM are shown. Scale bars, 50 μm.
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However, quantification of migrating late born Hb9+ MNs showed a dose-dependent reduction
of 10% in Olig2Shh+/- and 47% in Olig2Shh-/- embryos in brachial (ShhC/C 19 ± 1.2 cells, Olig2Shh+/17 ± 1.3 cells, Olig2Shh-/- 10 ± 1.4 cells), and 23% and 47% resp. in thoracic segments (ShhC/C 17
± 1.3 cells, Olig2Shh+/- 13 ± 1.4 cells, Olig2Shh-/- 9 ± 1.0 cells), suggesting that the deficit in MN
generation that we observe in Olig2Shh+/- and Olig2Shh-/- mice is greatest towards the end of MN
production (Figure 4.3). We did not observe a decrease in numbers of late born migrating MNs
in ChATShh-/- or NestinShh-/-.

Olig2Shh-/- mice are born alive and mobile and exhibit a full complement of MNs when compared
to litter controls (Figure 4.2B and 4.2C). These observations suggest that the earlier deficits in
MN generation in Olig2Shh-/- mice must be compensated by either extended production of MNs or
reduced apoptosis during the phase of programmed cell death. We did not observe MN
production beyond E12.5 but found reduced levels of Caspase3+ Hb9+ MNs in Olig2Shh-/- at
E12.5 indicating that reduced cell death of MNs at least in part will compensate for a reduced
rate of MN production in Olig2Shh-/- animals (Figure 4.3).
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Figure 4.3 Decreased numbers of late born MNs and rate of MN apoptosis in Olig2Shh-/-.
(A) Immunostaining and quantification of late born migrating Hb9+ MNs at E12.5 brachial and
thoracic segments. ShhC/C (n = 3-6 embryos), ChATShh-/- (n = 5), NestinShh-/- (n = 3-4), Olig2Shh+/(n = 3-4 embryos), Olig2Shh-/- (n = 4-5 embryos). Means ± SEM are shown. One-way ANOVA,
Dunnett’s multiple comparison post hoc test. ∗∗p<0.01, ∗∗∗p<0.001. Scale bars, 50 μm.
(B) Immunostaining and quantification of Hb9+ Caspase3+ apoptotic MNs. ShhC/C (n = 6
embryos), Olig2Shh+/- (n = 3 embryos), Olig2Shh-/- (n = 5 embryos). Means ± SEM are shown.
One-way ANOVA, Dunnett’s multiple comparison post hoc test. ∗∗p<0.01, ∗∗∗p<0.001. Scale
bars, 50 μm.
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We associated the degree of reduction in the numbers of MNs with the tissue specific efficiency
of Shh ablation in ChATShh-/-, NestinShh-/-, and Olig2Shh-/- embryos (Figure 4.4). The 80%
efficient ablation of Shh from MNs at brachial levels as well as the complete ablation of Shh
from MN and LFP in NestinShh-/- embryos, has no effect on MN numbers at E12.5. In contrast,
the complete ablation of Shh from MNs, LFP and about 50% of MFP in Olig2Shh-/- embryos
results in a Shh dose-dependent reduction of MN numbers at all levels and in all MN columns
(Figure 4.4, orange line). Together these results reveal that MN differentiation can proceed in
the absence of Shh signaling from the VZD sources MN and LFP but the efficacy of MN
generation becomes progressively impacted by dose-dependent reductions in Shh signaling from
the MFP. However, even the deficit in initial MN generation at E12.5, caused by the ablation of
Shh from more than 50% of all spinal cord sources, can be normalized by compensatory,
homeostatic mechanisms.
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Figure 4.4 Association of source specific Shh ablation with numbers of MNs generated.
Schematic representing Shh ablation within the genotypes and associated numbers of average
MNs for brachial and thoracic sections.
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CHAPTER 5:

Diminishment of pMN/Olig2+ cells during the phase of ventral
oligodendrogenesis results in reduced vOPC production

68

Reduced Shh signaling originating from MNs, LFP, or MFP leaves the pMN domain
impoverished of pMN/Olig2+ cells at the beginning of oligodendrogenesis (Figure 3.2).
Nevertheless, the pMN/Olig2+ cell population could recover during vOPC production by
increased precursor recruitment from dorsal precursor domains (Ravanelli and Appel, 2015),
proliferation of remaining precursor cells, or increased differentiation and amplification of vOPC
fated cells that have left the pMN domain. We therefore first visualized the size of pMN/Olig2+
population at the end of ventral oligodendrogenesis at E14.5. We find a moderate reduction in
the numbers of pMN/Olig2+ cells in ChATShh-/- embryos and an almost complete absence of
pMN/Olig2+ cells in NestinShh-/- and Olig2Shh-/- embryos compared to ShhC/C controls suggesting
that increased recruitment of precursors to the pMN domain does not occur in mutant embryos
(Figure 5.1 and Figure 5.2). We then determined whether pMN/Olig2+ cells and/or migrating
vOPCs in Olig2Shh-/- embryos increase their rate of proliferation during the phase of vOPC
production. We injected EdU into pregnant dams at E11.5, E12.5 and 13.5 and quantified the
numbers of pMN/Olig2+ cells 24h later. We found comparable broad EdU+ labeling throughout
the ventricular zone of Olig2Shh-/- mutants and controls suggesting overall progenitor
proliferation is not affected in mutants (Figure 5.2A). Within the pMN domain we observe a
25% decrease in the numbers of pMN/Olig2+ cells in ShhC/C controls over the course of vOPC
production from E12.5 to E14.5 (36 ± 2.2 cells to 27 ± 5.1 cells). In contrast, numbers of
pMN/Olig2+ cells in Olig2Shh-/- mutants decline to near undetectable levels during the same
period (12 ± 2.1 cells to 4 ± 2.8 cells) indicating a precocious exhaustion of the pMN/Olig2+ cell
population during vOPC generation (Figure 5.2B). We next determined the rate of proliferation
of pMN/Olig2+ cells in controls and mutants. In controls, we find a similar proliferative rate of
about 47% of pMN/Olig2+ cells at E12.5, E13.5 and E14.5.
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Figure 5.1 vOPCs continue to be diminished from the pMN at E14.5 in NestinShh-/-.
Immunostaining of Olig2 and DAPI on brachial and thoracic segments reveals the continued
depletion of Olig2 cells from the pMN of NestinShh-/- but not ChATShh-/- at E14.5.
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Figure 5.2 pMN Olig2 cells are reduced and do not increase rate of proliferation in the
ventricular zone of Olig2Shh-/- embryos between E12.5-E14.5.
(A) pMN domain proliferation in lumbar sections labeled by EdU incorporation in 24hr intervals
for E12.5- E14.5 in ShhC/C and Olig2Shh-/-.
(B) Total average Olig2 cells in pMN at E12.5-E14.5.
(C) Proliferation rate of Olig2 cells in pMN E12.5, E13.5, and E14.5
ShhC/C (n = 3 embryos), Olig2Shh-/- (n = 3 embryos). Means ± SEM are shown. Data were
analyzed by Student’s t test. ∗p < 0.05, ∗∗p < 0.01.
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Figure 5.3 Shh expressing LFP cells are in contact with the vOPC generating p* domain.
Immunostaining of Nkx2.2, nLacZ, and Olig2 to label LFP Shh expressing cells (Nkx2.2+
nLacZ+) in contact with p* domain vOPCs (Nkx2.2+ Olig2+).
ShhC/C (n = 6 embryos), Olig2Shh-/- (n = 6 embryos), NestinShh-/- (n = 3 embryos).
Means ± SEM are shown. One-way ANOVA, Dunnett’s multiple comparison post hoc test.
∗∗p<0.01.
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In contrast, in Olig2Shh-/- we find the rate of proliferation to be reduced at 37% at E12.5 and
E13.5, followed by a further decrease to 16% by E14.5 (Figure 5.2C). These results indicate that
the precocious exhaustion of the pMN/Olig2+ cell population is associated with a reduced
proliferation rate of precursor cells during OPC production which is compounded by reduced
numbers of pMN/Olig2+ cells that are present at the beginning of vOPC production.

Providing further evidence for decreased pMN domain activity at the beginning of vOPC
production at E12.5 we find a ~3-fold reduction in the size of p* precursor domain in NestinShh-/and Olig2Shh-/- embryos compared to controls (Figure 5.3). The p* domain forms at the ventral
border of the pMN domain and is marked by Olig2+/Nkx2.2+ cells (Qi et al., 2001; Zhou et al.,
2001; Fu et al., 2002; Agius et al., 2004). Interestingly, we found LFP* cells (marked by
Nkx2.2+ nLacZ+) in direct contact with Nkx2.2+ Olig2+ double positive cells of the p* domain
in ShhC/C controls, highlighting a cyto-architectural arrangement that could underpin the
disproportionate importance of LFP Shh compared to MFP Shh for the maintenance of the
pMN/Olig2+ cell population (Figure 5.3 and Figure 2.5C).

We next tested whether vOPC production in Olig2Shh-/- embryos recovers through increased
amplification of precursors once they have emerged from the pMN domain. We analyzed
numbers of EdU+ Olig2+ cells in the mantle zone (Figure 5.4A). While there are very few
Olig2+ cells in the mantle zone of mutants and controls at E12.5, with ongoing expansion of
these cells, we find a 3-fold and 15-fold reduction of Olig2+ cells at E13.5 and E14.5, resp.in
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Figure 5.4 vOPCs that exit the pMN domain do not increase rate of proliferation and
remain at reduced levels between E12.5-E14.5.
(A) Tracing of migrating Olig2 cells on representative lumbar sections with proliferation labeled
by EdU incorporation in 24hr intervals. EdU+ Olig2+ cells that have migrated out of the pMN
domain and into the mantle zone in lumbar sections at E12.5- E14.5. Box indicates pMN
domain, Olig2+ cells in the mantle zone (red), Olig2+ EdU+ cells (green).
(B) Total average Olig2 cells in mantle zone at E12.5, E13.5, and E14.5.
(C) Proliferation rate of Olig2 cells in mantle zone at E12.5, E13.5, and E14.5.
ShhC/C (n = 3-4 embryos), Olig2Shh-/- (n = 3-4 embryos). Means ± SEM are shown. Data were
analyzed by Student’s t test. ∗p < 0.05.
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mutants compared to controls (Figure 5.4B). The rate of proliferation among Olig2 cells in the
mantle zone in Olig2Shh-/- embryos is similar at E14.5 compared to controls suggesting that
vOPCs in mutants do not amplify at an increased rate compared to controls (Figure 5.4C). The
cells that do emerge from the pMN domain in Olig2Shh-/- embryos disperse as rapidly as their
control counterparts, resulting in a ventral spinal cord that is populated with nascent OPCs with a
7-fold lower density compared to controls (Figure 5.5). Additionally, we examined vOPC
proliferation dynamics within the same animal at E14.5 when posterior thoracic and lumbar
segments are still only producing vOPCs while anterior segments have begun producing dOPCs.
In these embryos we found no detectable increase in proliferation rate in any of the pMN,
mantle, or white matter (WM) areas in posterior thoracic and lumbar segments (Figure 5.6).
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Figure 5.5 Analysis of migrating Olig2 vOPC cell dispersion in Olig2Shh-/-.
Lumbar spinal cord sections from E12.5-E14.5 were binned into 6 equivalent zones, excluding
the ventricular zone, and average numbers of Olig2 cells in each zone were quantified. ShhC/C (n
= 2-3 embryos), Olig2Shh-/- (n = 2-3 embryos). Means ± SEM are shown.
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Figure 5.6 Proliferation rate of vOPCs is similar prior and during onset of dOPC
generation.
(A-D) Immunostaining for Olig2, EdU, and DAPI at lumbar (A and B) and posterior thoracic (C
and D). Arrows indicating co-expression of Olig2 and EdU.
(E) Schematic depicting areas analyzed.
(F and G) 24hr pulse chase with a single EdU injection to label proliferating Olig2 cells. Total
Olig2 cells and Olig2+ Edu+ double positive cells are reduced in the pMN, mantle zone, and
white matter at both (F) lumbar and (G) posterior thoracic segments in Olig2Shh-/- compared to
control.
ShhC/C (n = 3 embryos), Olig2Shh-/- (n = 3 embryos). Means ± SEM are shown. Data were
analyzed by Student’s t test. ∗p < 0.05. Scale bars, 50 μm.
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We then investigated whether the early deficits in vOPC production would result in reduced
numbers of ventral lineage vOPCs and vOLs in the postnatal spinal cord. We hypothesized two
scenarios (1) dorsal production of dOPCs and dOLs is increased in mutant animals compared to
controls or (2) the remaining vOPCs eventually give rise to normal numbers of vOL through
increased differentiation after E14.5. Consistent with the former possibility, we find that the
deficit in the numbers of vOPCs present at E14.5 becomes progressively normalized in a wave
from anterior to posterior beginning at E14.5 at the dorsal dOPC precursor domain at brachial
levels that coincides with the anterior start and subsequent posterior spread of dOPC generation
(Figure 5.7). Additionally, opposing the latter possibility, we find a ~7-fold reduction in the
numbers of CC1+ Nkx2.2+ OLs in Olig2Shh-/- compared to controls in the ventral white matter
(Figure 5.8A and 5.8D). Consistently, these cells are thought to be derived from the p* domain
(Vallstedt et al., 2005; Zhu Qiang et al., 2011; Tsai et al., 2012), which is severely reduced in
these mutants during development (Figure 5.3). Consistent with reduced numbers of myelinating
Nkx2.2+ CC1+ cells we find decreased white matter thickness of 20.7% ± 1.7% in Olig2Shh-/compared to ShhC/C controls at P20 (Figure 5.8C and 5.8F). To determine if Nkx2.2 expression
in CC1+ oligodendrocytes is a ventral marker at this time, we utilized tissue from P13 Msx3Cre; Sox10GFP/tdTomato animals, a generous gift of William Richardson’s lab. Ventrally derived
vOLs are labeled with GFP in this tissue, while dOLs are labeled with tdTomato (Figure 5.8J).
At P13 we find Nkx2.2 expression in the majority of vOLs but not in dOLs (Figure 5.8G-I).
Together, these observations suggest that the deficits in vOPCs caused by diminished numbers of
pMN/Olig2+ cells at the beginning of vOPC production do not recover and instead translate into
a reduction in the numbers of their postnatal OL derivatives of a similar magnitude.
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Figure 5.7 Total OPC numbers are normalized in Olig2Shh-/- embryos as onset of dOPC
generation begins anterior to posterior.
(A, B, C) Immunostaining for Olig2 on anterior thoracic, posterior thoracic, and lumbar sections
at E14.5.
(A) dOPCs and vOPCs intermingle and are indistinguishable at anterior thoracic segments.
(B) dOPCs are actively generated from the pMN at posterior thoracic segments, red brackets
indicate Msx3 domain.
(C) dOPCs have not begun to be generated at lumbar levels, while the pMN still generates
vOPCs, green brackets.
(D) Quantification of Olig2+ cells throughout A-P axis.
(E) Schematic of dOPC production from Msx3 domain and vOPC production from pMN domain
at E14.5.
ShhC/C (n = 3 embryos), Olig2Shh-/- (n = 3 embryos). Data were analyzed by Student’s t test.
∗p < 0.05, ∗∗p < 0.01. Scale bar, 50 μm.
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Figure 5.8 Depletion of ventrally derived Nkx2.2+ oligodendrocytes in Olig2Shh-/- white
matter.
(A) Representative tracing of Nkx2.2 expressing cells on P20 lumbar hemi sections.
(B) Colocalization of CC1 and Nkx2.2 in ventral white matter.
(C) Flouromyelin staining of ventral white matter.
(D) Quantification of average total white matter Nkx2.2+ CC1+ OL population.
(E) Quantification of average total grey matter Nkx2.2+ CC1+ OL population.
(F) Quantification of ventral horn white matter thickness relative to ShhC/C control.
(D-F) ShhC/C (n = 4-5 mice), Olig2Shh-/- (n = 4-5 mice).
(G) Labeling of ventral- and dorsal- oligodendrocyte lineage with Msx3-Cre; Sox10GFP/tdTomato.
(H) Representative tracing of Nkx2.2 expressing cells on P13 Msx3-Cre; Sox10GFP/tdTomato
lumbar hemi section.
(I) Immunolabeling for Nkx2.2 in Msx3-Cre; Sox10GFP/tdTomato ventral white matter. Coexpression of GFP and Nkx2.2 but not tdTomato and Nkx2.2.
Means ± SEM are shown. Data were analyzed by Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p <
0.001. Scale bars, 50 μm.
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CHAPTER 6:

In the absence of vOPCs the spinal cord becomes populated by
dOPCs of distinct morphology
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We next investigated the possibility that the postnatal spinal cord of Olig2Shh-/- animals is
populated by dOPCs in the absence of vOPCs. In support of this possibility, we find that OPCs
throughout the spinal cord, but most pronounced in the ventral horns, of mutant animals exhibit
stronger NG2 staining of their soma and proximal dendrites and less NG2 immunoreactivity on
their distal dendrites compared to controls (Figure 6A and 6C). We quantified dendritic
morphology using automated dendrite reconstruction of confocal z-stack images of OPCs in the
ventral horns of Olig2Shh-/- and control animals (Figure 6C). We found that distal dendrites of
OPCs in Olig2Shh-/- mice arborize 38% more frequently per unit length compared to controls
(50um2 ROI, ShhC/C 6.9 ± 0.9 vs Olig2Shh-/- 9.5 ± 0.9, dendrite order bin 7-9) (Figure 6D).
Dendrite length was similar for proximal and distal processes (Figure 6E). Dendrite volume was
increased about 30% in proximal dendrite bins (ShhC/C 10 ± 0.7cm3 vs Olig2Shh-/- 13 ± 0.7cm3,
dendrite order bin 1-3) (Figure 6F).

Lastly, we examined if the altered morphology of the dOPCs in Olig2Shh-/- would affect the
density of their tiling. We analyzed OPC density in two regions, the white matter dorsal
funiculus (DF) where dOPCs normally reside and the gray matter ventral horn (VH) where
vOPCs normally reside (Figure 6B). We found no differences in the density of NG2+ OPCs in
the DF (Figure 6I). In contrast, quantification of OPC density in Olig2Shh-/- VH exhibits a 39%
increased density of OPCs marked by NG2 compared to ShhC/C controls (ShhC/C 28 ± 0.6 cells vs
Olig2Shh-/- 39 ± 3.0 cells) (Figure 6H) leading to greater numbers of OPCs in the vicinity of MN
compared to ShhC/C controls (Figure 6G). These observations conform well with the stubby
appearance of dOPCs in Olig2Shh-/- animals and suggest that dOPCs in mutants occupy a smaller
tissue volume resulting in a larger packing density compared to controls.
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To determine if this stubby morphology of dOPCs we observe in Olig2Shh-/- mutant animals is an
intrinsic property of dOPCs or possibly an induced morphology due to the loss of vOPCs in these
animals, we analyzed the morphology of GFP and tdTomato OPCs in Msx3-Cre;
Sox10GFP/tdTomato animals (Figure 6J and 6K). We found that labeled grey matter dOPCs and
vOPCs exhibit a similar morphology as reconstructed in ShhC/C controls, indicating that the
stubby morphology of dOPCs in Olig2Shh-/- is likely a consequence of 1) induced increase of
over-proliferation due to the loss of vOPCs, 2) migration into ectopic ventral regions, 3) the loss
of vOPCs with which they likely communicate with.
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Figure 6A enlarged.
Figure 6. dOPCs populate ectopic regions of the postnatal spinal cord and reveal a unique
bushy morphology in Olig2Shh-/- mutants.
(A) NG2 staining on P20 lumbar spinal cord hemi sections. Scale bars, 50 μm.
(B) Schematic depiction of spinal cord areas analyzed, dorsal funiculus (DF), ventral gray
matter (GM).
(C) NG2 stained ventral GM in control and Olig2Shh-/-, revealing unique morphology of dOPCs
in Olig2Shh-/-. Example of automated tracing of OPCs. Reconstructed dendrites of OPCs. Scale
bars, 50 μm.
(D-F) Quantification of morphology of resident ventral GM OPCs binned by dendrite order of 3.
(D) Numbers of dendrites, (E) dendrite length, and (F) dendrite volume. Means ± SEM are
shown. ShhC/C (n = 3 mice), Olig2Shh-/- (n = 3 mice), 7-10 cells per animal. Data were analyzed
by Student’s t test. ∗p < 0.05, ∗∗p < 0.01.
(G) Representative maps of NG2/Pdgfra+ OPC (red dots) and MN (green X’s) locations in
ventral horn GM.
(H) Quantification of NG2+ OPCs density in ventral horn GM.
ShhC/C (n = 7 mice), Olig2Shh-/- (n = 6 mice).
(I) Quantification of NG2+ OPCs in DF of P20 mice.
ShhC/C (n = 3 mice), Olig2Shh-/- (n = 6 mice).
(H and I) Means ± SEM are shown. Data were analyzed by Student’s t test. ∗p < 0.05, ∗∗p <
0.01, ∗∗∗p < 0.001.
(J) Identification of dOPCs and vOPCs in P13 lumbar spinal cord sections of Msx3-Cre;
Sox10GFP/tdTomato.
(K) Reconstruction of dorsal dOPC and ventral vOPC morphology appears similar to ShhC/C in
(C).
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Chapter 7

Discussion: Part I

The integration of multiple sources of Shh contribute to the
production of vOPCs
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Shh signaling in the ventral spinal cord coordinates patterning and congruent growth during
ventral spinal cord development over an extended time period during which the size of the
ventricular zone increases exponentially and the same precursor domains become successively
utilized to produce distinct cell types. How Shh signaling becomes functionally modified
(adapted) to remain a critical morphogenic mechanism throughout this developmental period is
not fully understood. We provide genetic evidence that expression of Shh by earlier born
ventricular zone derivatives (VZDShh) participate in later ventricular zone activity. Part I of my
thesis describes how Shh production by LFP and nascent MNs is critical for the maintenance of
the Olig2 expressing precursor population in the pMN domain during the time of MN and
vOPCs production. While part II is focused on Shh ablation from all sources in Olig2Shh-/- results
in a failure to produce vOPCs and vOL without reducing MN production.

Timing and function of Shh expression by ventricular zone derivatives along the anterior
posterior extent of the spinal cord.

The Shh gradient emanating from notochord and floorplate during early neural tube formation
becomes distorted soon after the initial specification of the ventral precursor domains V3 to V0.
At these later stages of neural tube differentiation Shh signaling strength within the ventricular
zone of the ventral neural tube exhibit multiphasic and spatial patterns that cannot be explained
by a linear diffusion gradient of the morphogen that changes harmoniously over time and space
(Kicheva and Briscoe, 2015). Multiple adaptation mechanisms have been proposed to underlie
these temporal and spatial dynamic processes including storage of Shh in the extracellular matrix
and regulated burst like release as well as dynamic regulation of sensitivity towards Shh
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signaling in responding cells by cell autonomous mechanisms (Dessaud et al., 2007; Balaskas et
al., 2012; Touahri et al., 2012; Kicheva and Briscoe, 2015). An additional mechanism that could
contribute to the observed temporal and spatial patterns of Shh strength in the ventricular zone
along the ventral to dorsal axis at later stages of spinal cord development is the delivery of Shh
by VZD sources (VZDShh) to particular precursor domains. This idea is supported by the finding
that Shh becomes expressed by some VZD, like LFP and MNs, but causal evidence for their
function in ventricular zone activity has been lacking (Bitgood and McMahon, 1995; Oppenheim
et al., 1999; Danesin and Soula, 2017; Fogel et al., 2017).

We find Shh expression in cells flanking the V0 domain, in MNs and the LFP when Shh
signaling strength within the pMN domain rises coinciding with the switch from neurogenesis to
gliogenesis (Dessaud et al., 2007; Balaskas et al., 2012; Touahri et al., 2012; Kicheva and
Briscoe, 2015). We then provide genetic evidence for the causal role of VZDShh for pMN domain
activity since the ablation of VZDShh or more selectively of MNShh results in reduced numbers of
pMN/Olig2+ cells at the beginning of OPC production.

Interestingly, the relative contribution of VZDShh is spinal level specific. For example, the
ablation of VZDShh results in a pMN/Olig2+ loss of about 40% at brachial levels. Half of that
effect at brachial levels can be attributed to the expression of MNShh since the ablation of Shh
from cholinergic neurons by ChAT-Cre alone results in an almost 26% reduction in the size of
the pMN/Olig2+ population (Figure 3.2B). The remaining size of the pMN/Olig2+ population at
brachial levels in the ChATShh-/- spinal cord is highly similar to the average size of the
pMN/Olig2+ domain at thoracic levels in control spinal cords. Since thoracic MNs do not
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express Shh until the end of OPC production at E14.5, our observations reveal that the increased
size of the pMN domain at brachial levels is dependent on MNShh. Thus, the selective expression
of MNShh at brachial and lumbar levels suggests a possible mechanism for ensuring a
proportionate increase in the production of vOPCs at brachial and lumbar - compared to thoracic
levels that could sub-serve the increased numbers of MNs at limb levels.

Does Shh from different sources have distinct functions in the ventricular zone of the ventral
spinal cord? Three observations support origin specific functions of Shh in the ventral spinal
cord in the pMN domain:

(1) MFPShh but not VZDShh influences MN production (Figure 4.1). Consistent, ablation of Shh
in the MFP by Olig2-Cre is complete at the beginning of MN production while ablation of Shh in
VZD by Nestin-Cre only begins towards the end of MN generation (Figure 2.5 and Figure 2.7).
In further support of a critical role of MFPShh in MN generation we find a Shh gene dose
dependent reduction of the numbers of MNs of similar magnitude among early and late forming
MN columns as well as late born MNs still in transit at E12.5. Hence, based on the timing of Shh
expression and the consistent deficit in MN production throughout the period of MN generation,
the reduced rate of MN production must be associated with the reduction of MFPShh rather than
VZDShh. Strikingly, however, whether Shh expression is ablated from all VZD (NestinShh-/-) or
partially from the MFP in addition to LFP and MNs (Olig2Shh-/-), the pMN domain is left with
similar strongly reduced numbers of pMN/Olig2+ cells at the end of MN production (Figure
3.2B). Since ventral precursor domains form normally and a full complement of pMN/Olig2+
cells is induced in Olig2Shh-/- embryos (Figure 2.7), these results point to distinct functions of
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MFPShh and VZDShh in pMN domain activity: While MFPShh determines the rate of MN
production, VZDShh is critical to counteract the exhaustion of the pMN/Olig2+ population during
MN production.

(2) We find that the high threshold, Shh-dependent co-expression of Nkx2.2 and Olig2 (Fu et al.,
2002) occurs in cells that are in close proximity to LFP cells. Ablation of VZDShh results in a 3fold reduction in the numbers of Nkx2.2/Olig2 expressing cells at E12.5 (Figure 5.3). Additional
ablation of Shh from 50% of the MFP in Olig2Shh-/- did not increase the severity of this
phenotype (Figure 5.3). Thus, consistent with the anatomic juxtaposition of LFP* cells to p*
domain cells our gene ablation studies demonstrate that VZDShh is critical for the production of
the Nkx2.2 expressing subpopulation of ventral oligodendrocyte lineage cells.

(3) The dorsal most aspects of the pMN domain is almost completely devoid of Olig2+
expressing cells at the end of MN production at E12.5 in NestinShh-/- and Olig2Shh-/- embryos
(Figure 3.2A and Figure 3.4). Given the possibility that nascent MNs remain tethered to the
ependymal layer by cellular processes after leaving the ventricular zone and that early pioneer
OPCs elaborate cellular contacts selectively with MNs (Osterstock et al., 2018) it seems
plausible that the most distant pMN areas that may be out of reach of MFP and LFP are served
selectively by Shh from MNShh and other VZDShh.

Together, my data demonstrate that VZDShh impinges on pMN domain activity by inducing the
p* domain and by maintaining the pMN/Olig2 population by either preventing its exhaustion
during MN production, or alternatively, by attracting and/or inducing Olig2 expression in
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precursor cells that migrate ventral from the Dbx1 precursor domain to populate the pMN
domain at the end of MN production as is observed by Dbx1 based cell fate mapping in mice and
analysis of cell migration by time-lapse kinematics in zebrafish (Ravanelli and Appel, 2015).
Dbx1 based cell fate tracing in Olig2Shh-/- embryos might be able to distinguish these possibilities
in future experiments.

Ventral OPC production does not recover from an initial diminishment of pMN/Olig2+ cells.

The most striking feature of the phenotype of Shh ablation from VZD is the temporal and
qualitative segregation of the effects on MN and vOPC production. All genotypes are born with a
full complement of MNs. Hence VZDShh is neither required during MN production nor during
the phase of programmed cell death in our paradigms and the 30% deficit in MN production
caused by the partial ablation of Shh from MFP must become normalized by reduced
programmed cell death. In contrast ablation of VZDShh results in severely reduced vOPC
production which does not recover. We base this assertion on five observations: (1) during the
period of vOPC production the initial 2.5-fold diminishment of pMN/Olig2+ cells increases to
more than 6-fold reduction in pMN/Olig2+ cells compared to controls. (2) during the same
period, the numbers of Olig2+ cells that emerge from the pMN domain drop 15-fold. (3) the
proliferation rate of these nascent OPCs is equal or lower compared to their control counterparts.
(4) the numbers of mature vOLs that co-express ventral OPC marker Nkx2.2 together with CC1
is 7-fold reduced, and (5) the ventral spinal cord is populated by OPCs with an altered
morphology.
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On first sight the finding of a 7-fold reduction in mature vOLs but a qualitative complete absence
of vOPCs is at odds with the presumed ontogenetic derivation of vOL from vOPCs. However,
recent cell lineage studies in zebrafish document that OPCs from which OLs derive emerge first
and NG2 expressing OPCs present in the adult emerge later from the pMN domain (Ravanelli et
al., 2018). Hence, supported by our finding that the exhaustion of the pMN domain becomes
progressively more pronounced from E12.5 to E14.5, the stronger reduction in NG2 OPCs
compared to vOL in Olig2Shh-/- mice is consistent with the potential later production of NG2 glia
which may be at this time identified as OPCs.

Despite the severe reduction in vOPC production, the postnatal ventral spinal cord is populated
by NG2+ OPCs. Our data indicates that the OPCs in the ventral parenchyma of mutant animals
originate from the dorsal Msx3 precursor domain which begins to produce dOPCs in a Shhindependent manner at the end of vOPC production (Cai et al., 2005; Fogarty et al., 2005;
Vallstedt et al., 2005) due to the deficit in the numbers of Olig2+ cells in the ventral spinal cord
in mutants becoming normalized in an anterior to posterior wave starting at E14.5 after vOPC
production stops (Figure 5.7).

Together these results indicate that the Olig2Shh-/- mutant ventral spinal cord is mainly populated
by dOPCs while in controls only about 20% of all OPCs are of dorsal origin. This finding
suggests that the earlier emergence of vOPCs is critical for preventing the infiltration of dOPCs
throughout the spinal cord. Using genetic lineage tracing with Msx3-Cre; Sox10GFP/tdTomato
animals to identify the undisturbed morphology of dOPCs we determine that the morphology of
dOPCs found in Olig2Shh-/- is likely induced by the absence of vOPCs.

92

Figure 7. Integration of Shh from multiple sources contribute to vOPC production from
the pMN.
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CHAPTER 8:

Introduction to neuronal injury in the adult
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8.1 Peripheral nerve injury – model of motor neuron disease

In the familial amyotrophic lateral sclerosis (ALS) mouse model of SOD1G93A, MNs are more
susceptible to death after axotomy in pre-symptomatic animals than in controls (Mariotti et al.,
2002; Ikeda et al., 2005). This vulnerability suggests additional pathological mechanisms within
the CNS are involved besides disease induced denervation of muscle. OPCs in the ventral spinal
cord react to MN denervation from muscle in models of ALS and are a prominent contributor to
gliosis in the spinal cord of ALS patients (Kang et al., 2010, 2013). The genetic removal of the
mutant SOD1 gene in selectively OPCs led to an increase in the survival rate of SOD1 mutant
mice (Kang et al., 2013), implicating OPCs with a protective role for degenerating MNs.

The experimental nerve transection model is a useful paradigm that has been used for decades to
study aspects of MN disease due to several characteristic features that are common to both
including neuronal death, retrograde changes in neurons like synaptic rearrangement, and
mobilization of several glial types (Price et al., 1994). The temporal and spatial aspect of
experimental nerve axotomy provides three key advantages. (1) Injured MNs can be compared to
their uninjured counterparts within the contralateral spinal cord in the same animal. (2) Reactive
changes around injured MNs can be followed chronologically to identify a sequential pattern of
pathological events. (3) Unlike direct forms of CNS damage, peripheral axotomy induces highly
targeted and robust indirect damage to the spinal cord by affecting only MNs and sensory dorsal
root ganglion neurons, and therefore any reactive changes within the spinal cord are
consequences of signaling from these neurons.
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8.2 Synaptic reorganization in response to motor neuron injury and disease

Nerve injury induces remodeling of selective synaptic terminals on neurons to prioritize
regeneration over neurotransmission that could lead to further damage by excitotoxicity (Cheah
and Geffen, 1973; Koo et al., 1988; Sun and Zigmond, 1996; Zigmond, 1997; Zhou et al., 1998,
2001; Boeshore et al., 2004; Chandran et al., 2016). Specifically, excitatory glutamatergic
synapses on MNs seem targeted for elimination following axotomy. One hallmark aspect of ALS
pathology is the inability to effectively regulate glutamatergic excitotoxicity of MNs which have
lost contact to their muscle targets (Foran and Trotti, 2009; King et al., 2016), a feature which
may be due to a failure of synaptic remodeling. The current leading treatment for ALS patients is
the drug Riluzole, which acts to promote MN survival by reducing glutamatergic signaling
through multiple mechanisms (Kretschmer et al., 1998; Azbill et al., 2000; Dunlop et al., 2003).
Pharmacological blocking of glutamate signaling also prolongs MN survival after axotomy
(Greensmith et al., 1994), suggesting a potential common mechanism that is recapitulated in the
experimental nerve injury model. Consistent with glutamate excitotoxicity in contributing to the
death of alpha MNs in ALS, a key commonality between the remaining resistant MN populations
is their lack of excitatory glutamatergic input (Lalancette-Hebert et al., 2016). By reducing
glutamatergic input from 1a proprioceptive sensory neurons onto susceptible lumbar alpha MNs
through genetic ablation of gamma MNs or genetic degeneration of muscle spindles, LalancetteHerbet et al. were able to protect MNs, delay symptom onset, and extend lifespan of SOD1
mutant mice.
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8.3 The role of glia in synaptic reorganization
Microglia and astrocytes are the only CNS glial cell types that have been studied in the context
of injury induced synaptic stripping to date. In response to peripheral nerve injury, both of these
cell types become reactive, associate with the soma of neurons, and seem to display both
neuroprotective and neurotoxic properties in a context dependent manner.

8.3.1 Microglia

Microglia are broadly considered the immune cells of the CNS. However, they also have
important non-injury roles which include developmental pruning of synapses, as well as
monitoring the functional state of synapses during adult life and eliminating non-functioning
ones. In their resting form they are found throughout the CNS in a highly mobile and surveilling
state, routinely making brief contacts with synapses in an activity-dependent manner (Wake et
al., 2009). Microglia express receptors for all known neurotransmitters, allowing them to monitor
virtually all synapses in the CNS (Pocock and Kettenmann, 2007; Krabbe et al., 2012). Direct
evidence of microglial phagocytosis of synapses was demonstrated by observations during
developmental synaptic pruning where PSD95 excitatory puncta were found localized within the
membrane of microglial processes using both fluorescence and electron microscopy (Paolicelli et
al., 2011). Phagocytosis of synapses by microglia was functionally tested by genetic perturbation
of the classical complement cascade components or pharmacological minocycline inhibition of
microglial activation, and both led to reduced levels of phagocytosed excitatory glutamatergic
synapses (Schafer et al., 2012). Whether microglia are responsible for the stripping of synapses
in response to axotomy is still an open question.
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Upon activation, microglia can take on either a M1 pro-inflammatory or M2 anti-inflammatory
fate and often both types are induced in many CNS injury models (Hu Xiaoming et al., 2012;
Kumar et al., 2013; Kroner et al., 2014). Several lines of evidence are consistent with the
involvement of microglia with peripheral injury induced synaptic stripping of MNs. Microglia
react quickly to axotomy and contact 50% of all vGlut1 synapses on injured MNs within 24
hours (Casanovas et al., 2017). Consistent with this observation, MNs preferentially lose about
50% of excitatory vGlut1 synapses on their somas 7 days post axotomy (Alvarez et al., 2011).

8.3.2 Astrocytes

Astrocytes have been described as providing both neuroprotective functions such as providing
trophic support (Allaman et al., 2011) and maintaining synaptic homeostasis (Allen, 2014), as
well as pathological functions like killing neurons and oligodendrocytes (Liddelow et al., 2017).
In response to peripheral nerve injury, astrocytes become hypertrophic and up-regulate glial
fibrillary acidic protein (GFAP) (Grabber and Kreutzberg, 1986; Gilmore et al., 1990). This
astrocytic reactivity was observed to be temporally delayed compared to microglia which are the
first responders (Grabber and Kreutzberg, 1986). The temporal sequence of glial activation
raised the question if the microglial response was initialing astrocyte reactivity around MNs.
Blocking of microglial proliferation with cytosine arabinoside consequently reduced the
expression of the astrocyte marker GFAP around axotomized MNs, suggesting that the astrocyte
response is induced by initially responding microglia (Svensson et al., 1993). Additional
evidence of activated microglia signaling to astrocytes came from the finding that activated
microglia surrounding injured MNs release ATP which induces local astrocytes to also release
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more ATP (Pascual et al., 2012). ATP has neuroprotective properties, especially under
excitotoxic pathological conditions, as it strongly inhibits neurotransmitter release (particularly
glutamate) and hyperpolarizes neurons (Dunwiddle and Masino, 2001). The neuroprotective
function of astrocytes in response to spinal cord injury and axotomy was demonstrated by the
selective genetic ablation of the cytokine and growth factor signal transducer and activator of
transcription-3 (STAT3) from astrocytes (Okada et al., 2006; Herrmann et al., 2008; Tyzack et
al., 2014). The deletion of STAT3 from astrocytes using GFAP-Cre resulted in a significant
reduction of surviving neurons after axotomy. STAT3 signaling, via the secretion of
thrombospondin 1 (TSP-1), was shown to be required for the neuroprotective function of
activated astrocytes which facilitated the functional recovery of excitatory glutamatergic
synapses on MNs 2 weeks post axotomy (Tyzack et al., 2014). The role of TSPs in promoting
excitatory synapse formation has been repeatedly shown both in vivo and in vitro and therefore
is likely an integral mechanism of astrocyte mediated excitatory synapse formation both in
development and injury processes (Christopherson et al., 2005; Eroglu et al., 2009).
Interestingly, the initial synaptic stripping of axotomized MN synapses was unaffected in these
STAT3 mutants, suggesting that reactive astrocytes are not involved in the stripping of synapses,
but rather the protective re-establishment of new excitatory synapses (Tyzack et al., 2014).

8.3.3 Oligodendrocyte Precursor Cells

To date, no studies have shown the involvement of OPCs in developmental or injury induced
synaptic reorganization. However, given that OPCs have only relatively recently become
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accepted as a unique class of glia, their role in synaptic plasticity remains largely unknown.
There are a lot of features of OPC biology which make these cells highly suitable for regulating
synaptic plasticity. (1) OPCs are found tiled throughout the CNS white and gray matter
(Nishiyama et al., 2009). (2) OPCs constantly migrate and survey their environment with motile
filipodia (Hughes et al., 2013). (3) OPCs are the only known glial type to make glutamatergic
and GABAergic synapses with neurons (Bergles et al., 2000; Lin and Bergles, 2004). (4) OPCs
are migrate and respond to CNS injury. (5) OPCs maintain their synapses even while
proliferating (Ge et al., 2009). (6) OPCs have A1 adenosine receptors which are involved in
recruiting OPCs to sites of injury; adenosine is a byproduct of extracellular ATP (Zimmermann
et al., 1998) released by reactive microglia and astrocytes in response to injury (Pascual et al.,
2012).
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8.4 Thesis rationale: Part 2 - Function of vOPCs

(1) OPCs display many properties that suggest they play a role in synaptic plasticity.

(2) Olig2Shh-/- animals are born with a full complement of MNs and survive up to 3 weeks
postnatally.

(3) Olig2Shh-/- spinal cords are devoid of vOPCs, while dOPCs have spread to ectopic areas
including in the vicinity of MNs.

(4) In Olig2Shh-/- dOPCs have a characteristically unique dendritic morphology compared to
control dOPCs and vOPCs.

These findings indicated that Olig2Shh-/- animals may be useful to determine if peripheral nerve
injury induced synaptic stripping would be affected by the loss of vOPCs.
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CHAPTER 9:

vOPCs facilitate elimination of excitatory synapses from injured
MNs
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As observed previously (Alvarez et al., 2011), 9 days after sciatic nerve axotomy we find a
pronounced reduction in vGlut1 immunoreactivity in the immediate vicinity of injured MNs,
which we identified by retrograde labeling from the injury site with CTB, but not around
neighboring, uninjured MNs (Figure 9.1B and 9.1C’). In contrast, we find increased NG2
immunoreactivity around injured MNs compared to uninjured MNs in a pattern that suggested
that NG2 processes had taken up space around injured MNs that might be occupied otherwise by
vGlut1 labeled boutons on uninjured MNs (Figure 9.1D’ and 9.1E’). We next studied the
appearance of NG2 reactivity towards injured MNs in relationship to microglia and astrocytes,
both of which participate in protective pruning.

3 days post axotomy, immunohistochemical staining identified reactive Iba1+ microglia and
GFAP+ astrocytes (Figure 9.2A and 9.2B) surrounding ipsilateral injured MNs, however, we
did not observe a down-regulation of ChAT in MNs, enwrapment of MNs by NG2 cells, or loss
of vGlut1 synapses on injured MNs (Figure 9.2C and 9.2D). However, 9 days post axotomy
revealed continued microglial and astrocyte reactivity (Figure 9.2E and 9.2F), down-regulation
of ChAT in MNs, and the selective enwrapment of injured ipsilateral MNs by NG2 cells
concomitantly with the loss of vGlut1 synapses (Figure 9.2G and 9.2H). This temporal pattern
is in agreement that the activation of NG2+ OPCs occurs after microglial and astroglial
activation by neuronal injury (Xiang et al., 2015).
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Figure 9.1 Injured MNs lose glutamatergic synapses and are wrapped by NG2+ OPCs.
(A) Schematic depiction of CTB labeling and axotomy of MN pools contributing to the sciatic
nerve in control ShhC/C animals.
(B) CTB labeled MNs (arrows).
(C-E) Immunostaining with (C) vGlut1, (D) NG2, (E) merge, of ipsilateral ventral horns 9 days
post axotomy. (C’-E’) Dorsal axotomized MNs are selectively enwrapped by NG2 processes and
lose vGlut1 synapses compared to (C’’-E’’) ventral uninjured MNs.
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Figure 9.2 Time course of microglia, astrocyte, and OPC reactivity, and vGlut1 synapse
loss in response to axotomy.
(A-D) Reactive changes in the vicinity of MNs 3 days post sciatic axotomy in control ShhC/C.
(A) Iba1+ microglia and (B) GFAP+ astrocytes are reactive and change morphology around
injured ipsilateral MNs.
(C) NG2+ OPCs are not found to be reactive or change morphology around injured MNs.
(D) vGlut1 terminals are maintained on injured MN somas 3 days post axotomy.
(E-H) Reactive changes in the vicinity of MNs 9 days post sciatic axotomy.
(E) Microglia and (F) astrocytes remain reactive, in addition to the (G) selective enwrapment of
injured MNs by NG2 processes as well as (H) a loss of vGlut1 terminals on MN somas and
down-regulation of ChAT in injured MNs.
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We next investigated whether NG2 positive processes that appear to enwrap injured MNs could
belong to reactive microglia or astrocytes both of which are implicated in protective pruning
(Aldskogius and Kozlova, 1998; Tyzack et al., 2014; Zhu et al., 2010, 2016). We first double
labeled spinal cord sections of NG2DsRed transgenics for OPC, microglial, and astrocyte markers.
DsRed cell somas were found contacting injured MN somas and stained positive for NG2
(Figure 9.3A). In contrast, we did not find double labeling of DsRed and microglial marker Iba1
or astrocyte marker GFAP (Figure 9.3B and 9.3C). We next tested if NG2 expression could be
induced in non-OPCs using Tamoxifen induced Cre activity expressed from the NG2 locus. Here
we crossed NG2-CreERT2 with the reporter allele Rosa26mT/mG. Tamoxifen was administered
intraperitoneally daily for five consecutive days starting on day 4 post axotomy and spinal cords
were harvested on day 9 (Figure 9.3G). Five days of induction resulted in labeling throughout
the spinal cord white and gray matter in both control and axotomized animals (Figure 9.4A).
GFP labeled cells had morphology consistent with OPCs or mature oligodendrocytes (Figure
9.4B). GFP labeled OPCs were found wrapping injured MNs (Figure 9.3D-F). Remarkably,
GFP labeled cell somas were often found contacting microglia and astrocyte somas, which were
all commonly found in contact with injured MN somas, however, we found no double labeling of
GFP with microglial marker Iba1 (Figure 9.3D) or astrocyte markers GFAP (Figure 9.3E) and
S100b (Figure 9.3F). Together these gene expression tracing experiments indicated that NG2
expression in the post-natal lumbar spinal cord is restricted to OPCs.
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Figure 9.3 NG2 is not expressed by
microglia or astrocytes in response to
axotomy.
(A-C) Immunolabeling for OPC, microglia,
and astrocyte markers in NG2DsRed mice 9
days post axotomy.
(A) NG2+ OPCs reacting and wrapping
axotomized ChAT+ MNs, are double labeled
with DsRed. OPC (arrow head), pericyte (arrow).
(B) Iba1 microglia reacting to injured MNs are DsRed negative. OPC (arrow head), microglia
(arrow).
(C) GFAP astrocytes reacting to injured MNs are DsRed negative. OPC (arrow head), astrocyte
(arrow).
(D-F) Immunolabeling for OPC, microglia, and astrocyte markers in Rosa26mT/mG; NG2-CreERT2
induced mice 9 days post axotomy. GFP labeled cells located on MN somas in close proximity
with Iba1, GFAP, and S100b expressing cell somas and processes. GFP OPCs (arrowhead), Iba1
microglia, GFAP and s100b astrocytes (arrows).
(D) Iba1 microglia reacting to injured MNs are GFP negative.
(E) GFAP astrocytes reacting to injured MNs are GFP negative.
(F) s100b astrocytes reacting to injured MNs are GFP negative.
(G) Timeline of Tamoxifen injection.
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Figure 9.4 NG2-CreERT2 selectively labels OPCs and newly differentiated oligodendrocytes.
(A) 5 days of labeling in Rosa26mT/mG; NG2-CreERT2 successfully identifies OPCs and OLs that
have differentiated from labeled OPCs throughout spinal cord sections.
(B) Spinal cord sections with GFP labeled OPCs. GFP labeled cells displayed OPC morphology
or mature oligodendrocyte morphology.
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We next quantified the enwrapment by NG2 processes and pruning of vGlut1 synapses of injured
and non-injured MNs in ShhC/C controls, ChATShh-/-, and Olig2Shh-/- animals. Previous studies
showed that facial nerve MNs upregulate Shh in response to axotomy (Akazawa et al., 2004).
We therefore performed axotomy on ChATShh-/- animals to determine if Shh signaling from MNs
had an effect on loss of synapses following axotomy. We find that injured MNs are enwrapped
by NG2 processes (Figure 9.5A and 9.5B) and vGlut1 boutons are eliminated from their surface
to the same degree as observed in controls (ShhC/C 34.3% ± 3.6% vs ChATShh-/- 42.3% ± 1.5%)
(Figure 9.5G), demonstrating that Shh expression by MNs is not critical for these processes. In
contrast, Olig2Shh-/- mutants showed no evidence for enwrapment of injured MNs by NG2
processes (Figure 9.5C-E). We analyzed if astrocyte and microglia reactivity around axotomized
MNs was affected in Olig2Shh-/- mutants and found comparable activation of Iba1 and GFAP cells
around axotomized MNs in Olig2Shh-/- animals and controls (Figure 9.6). However, consistent
with the absence of NG2 processes around injured MNs, we found a preservation of vGlut1
synapses on axotomized MNs when compared to uninjured MNs in Olig2Shh-/- mutants (ShhC/C
34.3% ± 3.6% vs Olig2Shh-/- 65.5% ± 9.1%) (Figure 9.5F and 9.5G). Our results demonstrate
that ventral OPCs, in contrast to dOPCs, participate in protective pruning of glutamatergic
synapses upon motor neuron nerve injury.
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Figure 9.5 Injured MNs in Olig2Shh-/- are not wrapped by dOPCs and are not efficiently
stripped of vGlut1 synapses.
(A-C) Immunostaining of ventral horns with NG2, vGlut1, and ChAT 9 days post axotomy of
P20 ShhC/C, ChATShh-/-, and Olig2Shh-/- mice. Insets of (A’-C’) NG2, (A’’-C’’) vGlut1, and (A’’’C’’’) merge, asterix indicates MN cell bodies.
(D) Heatmaps of NG2 processes wrapping and contacting contralateral and ipsilateral MN
somas.
(E) Quantification of contralateral/ipsilateral ratio of NG2 processes contacting MN somas.
(F) Heatmaps of Ipsilateral and contralateral MN soma stained with vGlut1.
(G) Contralateral/ipsilateral ratio of surviving vGlut1 synapses on axotomized MN somas.
ShhC/C (n = 4 mice), ChATShh-/- (n = 3 mice), Olig2Shh+/- (n = 3 mice), and Olig2Shh-/- (n = 3 mice).
Means ± SEM are shown. Data were analyzed by Student’s t test. ∗p < 0.05, ∗∗p < 0.01. Scale
bars, 50 μm.
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Figure 9.6 Microglia and astrocytes are activated in Olig2Shh-/- mutants and controls in
response to axotomy.
(A) Iba1+ microglia are recruited, reactive, and change morphology around injured ipsilateral
MNs in ShhC/C and Olig2Shh-/-.
(B) GFAP+ astrocytes are recruited, reactive, and change morphology around injured ipsilateral
MNs in ShhC/C and Olig2Shh-/-.
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CHAPTER 10
Discussion Part II

First born ventral OPCs become critical for synapse remodeling
in response to motor neuron injury

112

Previous studies demonstrated that dOPCs react more readily than vOPC to demyelination
damage in the ventral spinal cord, but their differentiation capacity exhausts sooner than the one
of vOPCs (Crawford et al., 2016). These observations leave open the possibility that vOPCs have
selective functions that dOPCs cannot provide. Such functions might be most readily observable
in the ventral spinal cord. However, current models with ablated vOPCs also exhibit severe
deficits in ventral spinal cord development affecting other cell populations, including MN
production (Cai et al., 2005; Vallstedt et al., 2005; Yu et al., 2013), leading to embryonic
lethality and making it impossible to reveal a function of vOPCs that would require the presence
of an undisturbed ventral spinal cord. Here, however, we produced two mouse lines NestinShh-/and Olig2Shh-/- with severe reduction in vOPCs but a full complement of MNs providing us a
potential inroad for revealing vOPC specific functions in the ventral spinal cord. These mice are
born alive and mobile until their death at 3 weeks of age giving us a window of opportunity to
investigate MN OPC interactions upon MN injury in juvenile animals.

Nerve injury provides an experimental model to investigate injury induced synaptic plasticity
and the cell types involved. Microglia and astrocytes are known to play important roles in
synaptic rearrangement, but what about OPCs? Recent work describing cooperation between
microglia and oligodendrocyte precursor cells (OPCs) following CNS injury (Nishiyama et al.,
1997; Schonberg et al., 2007; Wu et al., 2010; Xiang et al., 2015; Jin et al., 2018) prompted us to
investigated if also OPCs play a role in responding to peripheral nerve injury and synaptic
stripping.
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Firstly, we reveal that the induction of Shh by MNs (Akazawa et al., 2004) is irrelevant for the
removal of vGlut1 synapses as ChATShh-/- MNs are still enwrapped and stripped of vGlut1
synapses post axotomy. Here, we implicate the first case of OPC involvement in synaptic
rearrangement in response to injury. Our results reveal that the wrapping of MN soma by vOPC
processes is critical for the removal of vGlut1 boutons selectively from injured MNs since we
neither observe wrapping nor removal of vGlut1 boutons from injured MNs in Olig2Shh-/- mice
despite the presence of dOPCs at greater density in the vicinity of MN and normal reactivity of
astrocytes and microglia towards injured MNs.
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Figure 10. First-born vOPCs become critical for synapse remodeling in response to adult
motor neuron injury.
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It is of interest that the increased dOPC density we observe in the mutant spinal cord is
potentially reminiscent of the situation in ALS. In SOD1G93A mice the density of OPCs in the
vicinity of MNs is increased 2-fold and their rate of proliferation is induced 20-fold compared to
healthy controls (Kang et al., 2010). Under normal conditions OPCs exhibit contact inhibition
with each other that regulates their densities (Hughes et al., 2013), and even while dividing OPCs
do not retract their dendrites and maintain their synaptic contacts during cytokinesis (Ge et al.,
2009). Therefore, the increased density of OPCs in SOD1G93A animals may reflect alterations in
dOPC morphology caused by over-proliferation, a situation which may underlie the phenotype in
Olig2Shh-/- mutant animals, allowing dOPCs to tile at higher densities.

The increased rate of OPC proliferation observed by Kang et al., in symptomatic SOD1 animals
is suggested to be in response to increased differentiation rate of OPCs to compensate for
massive apoptosis of mature oligodendrocytes. As discussed in previous sections, several studies
demonstrated that dOPCs have a higher efficiency for differentiating in response to induced CNS
injury (Zhu Qiang et al., 2011; Crawford et al., 2016), and these findings are consistent with the
possibility that the OPCs that have increased rates of recruitment, proliferation, and
differentiation in SOD1 models are of dorsal origin.

To determine if the death of oligodendrocytes was due to the loss of MNs, Kang et al., injected
the neurotoxin ricin into the sciatic nerve to determine if the induced death of MNs would result
in a similar phenotype as the SOD1 ALS model. The authors concluded that acute death of MNs
was insufficient to induce activation and recruitment of OPCs as seen in SOD1 symptomatic
mutants. However, due to the mechanism of action of the neurotoxin ricin to irreversibly inhibit
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protein synthesis, the possibility of injured MNs signaling to OPCs through a transcription and
translation dependent manner cannot be excluded.

Why is it that alpha MNs and mature oligodendrocytes selectively die in SOD1G93A (Kang et al.,
2013; Philips et al., 2013; Lalancette-Hebert et al., 2016) and other mouse models of ALS while
gamma MNs and OPCs do not? One possibility is that mature oligodendrocytes exhibit
dysfunction earlier on in the disease and undergo apoptosis which then reduces metabolic
support which is critical for MN survival (Kang et al., 2013; Ferraiuolo et al., 2016). Recently,
an additional mechanism has been suggested by Liddelow et al., with the finding that neurotoxic
A1 astrocytes are activated in ALS models and patients (Liddelow et al., 2017). In response to
inflammation and axotomy, neurotoxic A1 astrocytes are activated by microglia via the secretion
of three cytokines, Il-1α, TNF and C1q. When cultured in vitro, A1 neurotoxic astrocytes were
found to be incredibly toxic to alpha MNs (20% survive) but were not toxic to gamma MNs or
preganglionic MNs (the same neurons which are resistant in ALS). Additionally, mature
oligodendrocytes were found to be susceptible to the toxic secreted factors of A1 astrocytes but
not OPCs. These results mirror the cell types susceptible in ALS and may explain the selective
death of some cell types over others. And although in symptomatic SOD1 animals OPCs attempt
to compensate by increased differentiation, perhaps the mature oligodendrocytes lost (ventrallineage?) are of a different lineage than the oligodendrocytes generated by reacting OPCs
(dorsal-lineage?). In the light of our experiments, ascertaining whether the proliferating
population of OPCs in ALS is of dorsal or ventral origin might give insight whether the OPC
response in ALS is maladaptive.
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CHAPTER 11
Future directions
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So far the most useful tool to determine differences between the oligodendrocyte lineages is
Richardson’s Msx3-Cre; Sox10GFP/tdTomato animals. It would be of great interest to perform
axotomy on these mice to confirm if in control animals vOPCs preferentially enwrap axotomized
MNs. A drawback is the fact that labeling these two lineages cannot be done in conjunction with
ablating the ventral population with Olig2Shh-/- or NestinShh-/- since the specificity of Msx3 will be
lost with the introduction of other Cre drivers. Perhaps with the use of other recombination
systems like FLP-FRT, it can be possible to genetically label vOPCs and dOPCs in conjunction
with reducing Shh signaling from the ventral spinal cord. Additionally, performing RNA-seq on
purified and FACS sorted dOPCs vs vOPCs from Msx3-Cre; Sox10GFP/tdTomato animals would be
important to reveal if there really is transcriptional convergence between the two OPC lineages.

The phenotype of vOPC reduction and ectopic dOPC production I observe by reducing Shh
signaling may also be confirmed by specifically ablating these cells using Sox10DTA driven by
Nkx6.1-Cre. The Sox10DTA allele has been used previously to ablate each of the forebrain OPC
populations (Kessaris et al., 2006). This experiment was proposed by Palma Iannarelli, the
graduate student who sequentially and in combination ablated all the forebrain waves using the
Sox10DTA. In her studies OPCs from more caudal brain regions migrated into the forebrain to
compensate for the ablation of any of the forebrain OPC waves, a result which is similar to the
ectopic expansion of dOPCs I found in Olig2Shh-/- (Iannarelli, 2014).

Additionally, crossing the Msx3-Cre; Sox10GFP/tdTomato mice with SOD1G93A mice would shed
light on whether one or both OPC lineages undergo dysfunction in end-stage animals.
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Oligodendrocytes are produced throughout life and are important for learning (Sampaio-Baptista
et al., 2013; McKenzie et al., 2014; Xiao et al., 2016). It would therefore be interesting to
investigate if the later born dOPCs are selectively important for learning. dOPCs could be
selectively ablated in adult animals by the generation of Sox10lox-STOP-lox-TTA and Rosa26TetO-DTA
mice lines and combining these two alleles with Msx3-Cre. In these mice, TTA will be produced
in dOPCs but will not be able to activate the Rosa26DTA allele until tamoxifen is added. Since
dOPCs are phylogenetically younger and display a high efficiency for generating new
oligodendrocytes in adult animals, they may be the lineage which is involved in learning
dependent myelination.
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CHAPTER 12
Methods

121

Table 1.
REAGENT or RESOURCE
Antibodies
Chicken polyclonal anti beta Galactosidase

SOURCE

IDENTIFIER

Abcam

Goat polyclonal anti beta Galactosidase

Biogenesis

Goat polyclonal anti Choline acetyltransferase

Millipore

Rabbit polyclonal anti Olig2

Millipore

Mouse monoclonal anti APC (Ab-7) (CC1)

Millipore

Mouse monoclonal anti Nkx2.2

DSHB

Rabbit polyclonal anti NG2

Millipore

Rat monoclonal anti CD140a (Pdgfra)

BD

Rabbit polyclonal anti Iba1

Wako

Rabbit polyclonal anti GFAP

Sigma Aldrich

Rabbit monoclonal anti S100 beta
Guinea Pig polyclonal anti vGlut1

Sigma Aldrich
Millipore

Rabbit polyclonal anti nNos
Mouse monoclonal Ankyrin G (AnkG) (463)

Immunostar
Santa Cruz

Mouse monoclonal Lim3 (Lhx3)

DSHB

FluoroMyelin Red

Thermofisher

Rabbit polyclonal Lim1
Guinea Pig polyclonal Hb9
Rabbit polyclonal FoxA2
Rabbit polyclonal Pax6
Rabbit polyclonal Dbx1
Rabbit polyclonal Isl1/1
Rabbit polyclonal anti Nkx2.2
Donkey anti rabbit Alexa 488

Gift Jessell Lab
Gift Jessell Lab
Gift Jessell Lab
Gift Jessell Lab
Gift Jessell Lab
Gift Jessell Lab
Gift Jessell Lab
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch

Cat# ab9361,
RRID:AB_307210
Cat# 4600-1409,
RRID:AB_2314510
Cat# AB144P,
RRID:AB_2079751
Cat#AB9610,
RRID:AB_570666
Cat# OP80,
RRID:AB_2057371
Cat# 74.5A5,
RRID:AB_531794
Cat# AB5320,
RRID:AB_11213678
Cat# 558774,
RRID:AB_397117
Cat# 019-19741,
RRID:AB_839504
Cat# SAB4501162,
RRID:AB_10746077
Cat# SAB5500172
Cat# AB5905,
RRID:AB_2301751
Cat# 24431, RRID:AB_572255
Cat# sc-12719,
RRID:AB_626674
Cat# 67.4E12,
RRID:AB_2135805
Cat# F34652,
RRID:AB_2572213
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cat# 711-545-152,
RRID:AB_2313584
Cat# 715-545-150,
RRID:AB_2340846
Cat# 706-545-148,
RRID:AB_2340472
Cat# 705-545-147,
RRID:AB_2336933
Cat# 711-165-152,
RRID:AB_2307443
Cat# 715-165-150,
RRID:AB_2340813

Donkey anti mouse Alexa 488
Donkey anti guinea pig Alexa 488
Donkey anti goat Alexa 488
Donkey anti rabbit Cy3
Donkey anti mouse Cy3
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Donkey anti guinea pig Cy3

Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch
Jackson
ImmunoResearch

Cat# 706-165-148,
RRID:AB_2340460
Cat# 712-165-153,
RRID:AB_2340667
Cat# 711-585-152,
RRID:AB_2340621
Cat# 715-585-150,
RRID:AB_2340854
Cat# 706-585-148,
RRID:AB_2340474
Cat# 712-585-153,
RRID:AB_2340689
Cat# 703-175-155,
RRID:AB_2340365
Cat# 705-175-147,
RRID:AB_2340415
Cat# 715-175-150,
RRID:AB_2340819
Cat# 706-175-148,
RRID:AB_2340462

Roche
Sigma Aldrich

10745740001; CAS 7240-90-6
T5648; CAS 10540-29-1

Thermofisher
Thermofisher

C10340
C34776

Gonzalez-Reyes
L, et al., 2012
The Jackson
Laboratory
The Jackson
Laboratory
Dessaud E, et al.,
2007
The Jackson
Laboratory
The Jackson
Laboratory
The Jackson
Laboratory
The Jackson
Laboratory

MGI:5440762

Neurolucida Explorer

CNIC, Mount
Sinai School of
Medicine
MBP

ImageJ ver1.60

NIH

http://research.mssm.edu/cnic/
tools-ns.html
RRID:SCR_013798
https://www.mbfbioscience.co
m/neurolucida-explorer
https://imagej.net/Fiji/Downloa
ds

Donkey anti rat Cy3
Donkey anti rabbit Alexa 594
Donkey anti mouse Alexa 594
Donkey anti guinea pig Alexa 594
Donkey anti rat Alexa 594
Donkey anti chicken Cy5
Donkey anti goat Cy5
Donkey anti mouse Cy5
Donkey anti guinea pig Alexa Cy5
Chemicals, Peptides, and Recombinant Proteins
X-Gal
Tamoxifen
Critical Commercial Assays
Click-iT EdU
Cholera Toxin Subunit B (recombinant) Alexa Fluor 555
Experimental Models: Organisms/Strains
Mouse: Shhtm1Ahk
Mouse: B6;129S6-Chattm1(cre)Lowl/J
Mouse: B6.Cg-Tg(Nes-cre)1Kln/J
Mouse: Olig2tm1(cre)Tmj
Mouse: Tg(Cspg4-DsRed.T1)1Akik/J
Mouse: B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J
Mouse: Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J
Mouse: B6.FVB(Cg)-Tg(ChatEGFP/Rpl10a,Slc18a3)DW167Htz/J
Software and Algorithms
NeuronStudio

JAX: 006410
JAX: 003771
MGI:3774124
JAX: 008241
JAX: 008538
JAX: 007576
JAX: 030250
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Transgenic Mice

The following mouse strains were used and genotyped as described previously: Shh-nLZC/+
animals (Gonzalez-Reyes et al., 2012), Chat-Cre (Rossi et al., 2011), Olig2-Cre (Dessaud 2007),
Nestin-Cre (Tronche et al., 1999), Chat-EGFP/Rpl10a (Doyle et al., 2008), NG2DsRedBac (Zhu
et al., 2008), NG2-CreERT2 (Zhu et al., 2011), Rosa26mTmG (Muzumdar et al., 2007). Mice were
maintained on a C57BL/6 background. Noon on the day of the plug was considered E0.5. Mice
were kept on a 12 hr dark/light cycle and the day of birth designated P1. All animal experiments
were approved by the Institutional Animal Use Care Committee at CUNY.

Retrograde Motor Neuron Labeling

Animals were sacrificed 1 week after (1ug/ul) Cholera Toxin Subunit B (Recombinant), Alexa
Fluor 594 (Thermofisher) was injected in four 2ul injections into the right calf muscle.

Surgery

For axotomy, the right sciatic nerve was exposed at midthigh level under isoflurane anesthesia
and a 2-mm segment of sciatic nerve was removed to avoid regeneration. The wound was closed
with silk sutures. Mice were perfused 3 or 9 days after surgery. All surgeries were performed
under CUNY CCNY IUCUC guidelines.
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In vivo EdU Assay

Pregnant dams received EdU (5-ethynyl-20 -deoxyuridine, Invitrogen) by intraperitoneal
injection (50 mg/kg) and sacrificed after 24 hours. Tissue sections were stained using the
‘‘Click-iT Plus’’ EdU Alexa Fluor 647 Imaging Kit (Thermofisher).

Tissue Processing

All mice were sacrificed using an overdose of anesthetic, subjected to transcardial perfusion with
4% (w/v) paraformaldehyde (PFA) in 0.1 M PBS pH 7.4. Spinal cords and embryos were
dissected, postfixed in 4% PFA for 1 hr at 4°C, cryoprotected with 30% (w/v) sucrose in 0.1M
PBS for 24–48 hr, embedded and frozen in OCT medium, and stored at −80°C. Tissues were
sectioned at 20 μm and collected onto glass slides.

Immunocytochemistry and Microscopy

20um thick spinal cord cryosections were air dried for 30 min. Then sections were washed with
PBS for 10 mins and with 0.3% [v/v] Triton X-100 in PBS for 20 min. Sections were then pretreated with blocking solution (10% [v/v] horse serum and 0.3% [v/v] Triton X-100 in PBS) for
90 mins and incubated with primary antibodies overnight at 4C. The next day, following 3 PBS
washes the sections were incubated with secondary antibodies for 2 hr at 20C–25C. A table for
all antibodies and reagents used is provided above. For cell counts, at least 3 sections per animal
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from 3 mice were examined, unless otherwise noted. Images were acquired using a Zeiss
LSM880 confocal microscope.

Statistical analysis was performed using Prism 7 (Graphpad Software Inc.) A normality test
(Shapiro-Wilk test) was applied to all data before analysis for statistical significance. Datasets
which passed the normality test were subjected to parametric analysis. Analysis of multiple
groups was made using one-way ANOVA followed by the Tukey or Dunnett’s post hoc analysis
tests. For 2-groups analyses, unpaired Student’s t test was used. The data are presented
graphically as: ∗(p < 0.05), ∗∗(p < 0.01), and ∗∗∗(p < 0.001).

Morphological Analysis of OPCs

Images of NG2 stained 20um thick spinal cord sections were captured with the LSM880 Zeiss
confocal microscope using the using oil immersion 40x objective. Z stacks were taken with
0.5um step intervals, with an average of 35-40 images per stack. 50um2 regions of interest were
designated with an OPC soma in the center. Dendrites were reconstructed in 3D using automatic
tracing in NeuronStudio (Wearne 2005). Reconstructed OPCs were analyzed with
NeuroExplorer software for dendritic order analysis. Data for dendrites were binned in groups of
3. For cell morphology analysis, 7-10 cells were reconstructed per animal from three mutants and
controls.
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Analysis of NG2 processes and vGlut1 Terminals on MN Somas

20um spinal cord sections from P20 lumbar L4-L6 segments with Chat-EGFP MNs were stained
with vGlut1 and NG2 antibodies. Dorsal motor pool MNs were outlined in ImageJ in the ChATEGFP channel and the outline was expanded by 15 pixels on both contralateral and ipsilateral
sides of axotomy. MN outlines were used as regions of interests (ROIs) in vGlut1 and NG2
stained channels. Heatmaps were generated to threshold each image using the Heatmap
Histogram plugin for ImageJ. Ratios were generated by comparing contralateral and ipsilateral
MNs for each section to control for staining variability between sections.
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